Original Article
Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study
N Engl J Med 2006; 355:260-269July 20, 2006
- Abstract
Background
The importance of heart failure with preserved ejection fraction is increasingly recognized. We conducted a study to evaluate the epidemiologic features and outcomes of patients with heart failure with preserved ejection fraction and to compare the findings with those from patients who had heart failure with reduced ejection fraction.
Methods
From April 1, 1999, through March 31, 2001, we studied 2802 patients admitted to 103 hospitals in the province of Ontario, Canada, with a discharge diagnosis of heart failure whose ejection fraction had also been assessed. The patients were categorized in three groups: those with an ejection fraction of less than 40 percent (heart failure with reduced ejection fraction), those with an ejection fraction of 40 to 50 percent (heart failure with borderline ejection fraction), and those with an ejection fraction of more than 50 percent (heart failure with preserved ejection fraction). Two groups were studied in detail: those with an ejection fraction of less than 40 percent and those with an ejection fraction of more than 50 percent. The main outcome measures were death within one year and readmission to the hospital for heart failure.
Results
Thirty-one percent of the patients had an ejection fraction of more than 50 percent. Patients with heart failure with preserved ejection fraction were more likely to be older and female and to have a history of hypertension and atrial fibrillation. The presenting history and clinical examination findings were similar for the two groups. The unadjusted mortality rates for patients with an ejection fraction of more than 50 percent were not significantly different from those for patients with an ejection fraction of less than 40 percent at 30 days (5 percent vs. 7 percent, P=0.08) and at 1 year (22 percent vs. 26 percent, P=0.07); the adjusted one-year mortality rates were also not significantly different in the two groups (hazard ratio, 1.13; 95 percent confidence interval, 0.94 to 1.36; P=0.18). The rates of readmission for heart failure and of in-hospital complications did not differ between the two groups.
Conclusions
Among patients presenting with new-onset heart failure, a substantial proportion had an ejection fraction of more than 50 percent. The survival of patients with heart failure with preserved ejection fraction was similar to that of patients with reduced ejection fraction.
Media in This Article
Figure 1
Adjusted Survival Curves for Patients with Heart Failure with Reduced or Preserved Ejection Fraction over the Year after the First Hospital Admission.Table 1
Characteristics of Patients.Article Activity
- Article
Heart failure has classically been considered to be a clinical syndrome associated with cardiac dilatation and impaired cardiac contractility.1 However, studies have found that increasing numbers of patients presenting with clinical heart failure have an ejection fraction of more than 50 percent.1-3 This entity, which has been termed “heart failure with preserved ejection fraction,” is attributed to abnormalities of diastolic function, although the exact mechanism is debated.4,5
Prior data suggest that patients who have heart failure with preserved ejection fraction tend to be older, to be female, and to have a history of hypertension.1,3,6,7 The prognosis for such patients has been reported to be better than that for patients who have heart failure with reduced ejection fraction.3,6,8-10 However, most available data are based on ambulatory populations, with less information on patients admitted to the hospital with heart failure.3,6,8-12 The results of these studies have been inconsistent or conflicting, and the estimates of rates of mortality and rehospitalization vary widely, since they are derived from heterogeneous populations with different inclusion criteria.2,6,13,14
We conducted a large, population-based cohort study to evaluate the epidemiologic features and outcomes of patients with heart failure with preserved ejection fraction and to compare the findings with those from patients who had heart failure with reduced ejection fraction.
Methods
Patients
Between April 1, 1999, and March 31, 2001, we identified all newly admitted patients with a primary discharge diagnosis of heart failure from 103 hospitals in Ontario, Canada, as part of the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study. The criteria for the selection of the sample population have been described previously.15 The hospitals included teaching hospitals and community-based institutions from both rural and urban settings. All had admitted more than 30 patients with heart failure during the two years of sampling.
At each hospital, patients with heart failure (International Classification of Diseases, Ninth Revision, Clinical Modification code 428) were identified by using the Canadian Institute for Health Information hospital discharge abstracts.16,17 On the basis of chart review, we included only patients presenting to the hospital for the first time with heart failure who met the Framingham Study criteria for heart failure.18
We excluded patients who had a previous recorded admission for heart failure, those in whom heart failure developed after admission (i.e., as an in-hospital complication), those who were transferred from another acute care facility, those 105 years of age or older, nonresidents of the province of Ontario, and those with an invalid Ontario health-insurance-card number. We also excluded all patients whose left ventricular ejection fraction had not been evaluated by echocardiography, left ventricular angiography, or radionuclide angiography and all patients who had any severe primary left-sided valvular abnormality on echocardiography.
The records of patients who met the inclusion and exclusion criteria were reviewed for abstraction of clinical data. For hospitals treating at least 125 suitable candidates during the study period, a random sample of 125 charts was reviewed. For hospitals that treated fewer than 125 suitable candidates during the study period, all charts were reviewed.
Patients with documented left ventricular function were divided into three groups: those with an ejection fraction of less than 40 percent (heart failure with reduced ejection fraction), those with an ejection fraction of 40 to 50 percent (heart failure with a borderline ejection fraction), and those with an ejection fraction of more than 50 percent (heart failure with preserved ejection fraction). Those with an ejection fraction of 40 to 50 percent were excluded from most of the analyses, because we wanted to have two distinct groups for comparison. Approval of the institutional ethics review board was obtained from each participating institution before the study. Because the study involved only the review of records obtained as a part of routine medical care, no patient consent was required.
Data Collection and Variable Definitions
We defined a set of clinical and demographic factors that may potentially be associated with death from heart failure and that were available from chart review. For each patient, the time to death was calculated by linking the hospital discharge data to the Registered Persons Database (RPDB) with the use of each patient's encrypted health care number. The RPDB provides data on the vital status of residents of Ontario and records deaths both in and out of the hospital. Data for each patient were censored one year after admission, so that there was one year of follow-up for each patient.
The primary end point of the study was death from any cause after the index hospitalization for heart failure. Secondary outcomes included rates of 30-day and 1-year readmission to the hospital for heart failure. Other secondary outcomes were in-hospital complication rates, including myocardial infarction, admission to a coronary care unit or intensive care unit (ICU), renal failure, hypotension, shock, and the need for mechanical ventilation.
Statistical Analysis
The demographic and clinical characteristics of patients with heart failure with preserved ejection fraction and of those with reduced ejection fraction were compared. Dichotomous variables were compared by the chi-square test and continuous variables by Student's t-test.
We used Cox proportional-hazards analysis to identify factors associated with an increased risk of death after hospitalization for heart failure. Candidate variables were included in the initial Cox regression model if they were associated with death in a univariate analysis (P<0.20). Backward variable elimination, with an elimination criterion of a P value of more than 0.05, was then used to create a parsimonious model for predicting death. By forcing an indicator variable denoting ejection-fraction group into the model at each stage of the variable selection process, we determined the adjusted hazard ratio for death among patients with reduced ejection fraction as compared with those with preserved ejection fraction. We determined that the assumption of proportional hazards was met in all Cox regression models. Survival curves were constructed for the two ejection-fraction groups after adjustment for all covariates in the final model. In a separate analysis, the independent predictors of death for patients with reduced ejection fraction and for patients with preserved ejection fraction were determined with the use of Cox proportional-hazards regression and methods similar to those described above. The results are shown as means ±SD unless otherwise indicated. Statistical analysis was performed with SAS software, version 8.2; a P value of less than 0.05 was considered to indicate statistical significance.
Results
A total of 9945 patients were admitted and met the predefined criteria for heart failure at the 103 participating hospitals during the study period. Of these, 5775 patients were excluded because echocardiography, angiography, or nuclear scintigraphy was not performed at admission. Another 717 patients who had undergone echocardiography were excluded because their ejection fraction had not been documented, and 649 were excluded because they had severe aortic or mitral valve disease. Two patients were excluded because they did not have a valid health-card number.
Among the remaining hospitalized patients with heart failure whose ejection fraction had been measured, 880 (31 percent) had a preserved ejection fraction (more than 50 percent) and 1570 (56 percent) had a reduced ejection fraction (less than 40 percent). The remaining 352 (13 percent) had a borderline ejection fraction (40 to 50 percent); to provide more distinct comparison groups, the data from the group with borderline ejection fraction were excluded from most of the presented data analysis.
Clinical Characteristics
The clinical characteristics of the study patients are shown in Table 1Table 1
Characteristics of Patients.. Patients with preserved ejection fraction were older (75 vs. 72 years, P<0.001), were more likely to be female (66 percent vs. 37 percent, P<0.001), and had a significantly higher incidence of hypertension (55 percent vs. 49 percent, P=0.005) than those with reduced ejection fraction. Patients with preserved ejection fraction had significantly lower rates of other modifiable cardiac risk factors, including smoking, diabetes, and hyperlipidemia. Patients with preserved ejection fraction also had lower rates of peripheral vascular disease, angina, prior myocardial infarction, and prior coronary-artery bypass surgery. However, patients with preserved ejection fraction had significantly higher rates of atrial fibrillation (31.8 percent vs. 23.6 percent, P<0.001) and chronic obstructive pulmonary disease (17.7 percent vs. 13.2 percent, P=0.002).Table 2Table 2
Presenting Symptoms and Signs of Heart Failure. summarizes the symptoms and clinical findings of the two groups. The presenting symptoms in patients with preserved ejection fraction were largely similar to those in patients with reduced ejection fraction. The main differences were that patients with preserved ejection fraction had lower rates of acute pulmonary edema, paroxysmal nocturnal dyspnea, and S3 and a higher rate of bilateral ankle edema.Hospital Course
Table 3Table 3
In-Hospital Care, Complications, and Outcomes. shows in-hospital treatment and complications. A cardiologist was the primary physician for 33.6 percent of patients with reduced ejection fraction but for only 24.7 percent of patients with preserved ejection fraction (P<0.001). Cardiology consultations were obtained for 43.8 percent of patients with reduced ejection fraction but for only 37.3 percent of patients with preserved ejection fraction (P=0.002). Although the rates of hypotension and cardiogenic shock were significantly higher among patients with reduced ejection fraction than among those with preserved ejection fraction, the rates of renal failure, cardiac arrest, acute coronary syndrome, and admission to a coronary care unit or ICU did not differ significantly between the two groups.Outcomes
The unadjusted mortality and readmission rates for the two groups are summarized in Table 3. At 30 days, the mortality rate among patients with reduced ejection fraction was 7.1 percent, as compared with 5.3 percent among those with preserved ejection fraction, but this difference was not significant (P=0.08). The mortality rates at one year were 25.5 percent and 22.2 percent, respectively (P=0.07). Even after adjustment for other significant predictors, the risk of death was not significantly higher among patients with reduced ejection fraction than among those with preserved ejection fraction at one year (hazard ratio, 1.13; 95 percent confidence interval, 0.94 to 1.36; P=0.18). The adjusted survival curves are shown in Figure 1Figure 1
Adjusted Survival Curves for Patients with Heart Failure with Reduced or Preserved Ejection Fraction over the Year after the First Hospital Admission.. The one-year rate of readmission for heart failure was 16.1 percent among patients with reduced ejection fraction and 13.5 percent among those with preserved ejection fraction (P=0.09). The unadjusted combined one-year end point of death and readmission for heart failure was 36.1 percent for patients with reduced ejection fraction and 31.1 percent for those with preserved ejection fraction (P=0.01). Patients with borderline ejection fraction (40 to 50 percent) had unadjusted mortality rates of 5.1 percent at 30 days and 21.3 percent at 1 year. Although these mortality rates were not significantly different from those among either patients with reduced ejection fraction or patients with preserved ejection fraction, they were more similar to the mortality rates among patients with preserved ejection fraction.The predictors of death among patients with preserved ejection fraction included age, systolic blood pressure, the presence of peripheral vascular disease, hyponatremia, a history of cancer, dementia, renal dysfunction, dialysis, anemia, and respiratory rate. The predictors of the risk of death among patients with a reduced ejection fraction were similar but also included the presence of cirrhosis and did not include the presence of cancer, dialysis, or anemia or the respiratory rate. The results of these multivariate analyses are reported in Table 4Table 4
Multivariate Models of One-Year Mortality in the Entire Cohort of Patients with Heart Failure, in Patients with Heart Failure and Reduced Ejection Fraction, and in Patients with Heart Failure and Preserved Ejection Fraction..Discussion
We performed a large, population-based cohort study examining the clinical features and outcomes of patients admitted to the hospital for the first time with heart failure. We found that about one third of the patients admitted with heart failure in whom left ventricular function was measured had an ejection fraction of more than 50 percent. These patients were more likely to be women, were older, and were more likely to have a history of hypertension than those with an ejection fraction of less than 40 percent. These observations are consistent with those of some previous reports.7,9,19 In contrast to previous studies, however, our study found that patients with a reduced ejection fraction had higher rates of diabetes, coronary artery disease, and hyperlipidemia; this finding is in keeping with the concept that myocardial infarction or ischemia constitutes a major cause of heart failure associated with a low ejection fraction. Patients with a preserved ejection fraction had a significantly higher rate of atrial fibrillation, which may be both a consequence and a precipitant of clinical deterioration in this setting.20 The rates of most other noncardiac associated conditions did not differ significantly between the groups, except for chronic obstructive lung disease, which was more frequent in the group with preserved ejection fraction.
Although subtle differences between groups were observed on physical examination and review of presenting symptoms, these were largely unhelpful in distinguishing between the two types of heart failure defined on the basis of ejection fraction. This finding is also consistent with those of other studies7 that failed to discriminate between the two conditions on clinical grounds. Imaging methods such as echocardiography are the current mainstay for distinguishing between these two entities. Although the diagnosis of heart failure itself is determined clinically, biomarkers such as B-type natriuretic peptide and other emerging candidates may help confirm the diagnosis in patients who do not have a reduced ejection fraction.7,21
Our principal findings are related to morbidity and mortality. Patients with heart failure with a preserved ejection fraction had complication rates that were similar to those of patients with a reduced ejection fraction, including similar rates of cardiac arrest, acute coronary syndrome, renal failure, and admission to the ICU or coronary care unit. Despite similar rates of in-hospital complications in the two groups, patients with a preserved ejection fraction were less likely to receive primary care from a cardiologist and were less likely to have had a cardiology consultation than patients with a reduced ejection fraction. It is not clear whether this difference had an effect on the outcomes of our cohort.
Our study showed that patients with a preserved ejection fraction had high 30-day and 1-year mortality rates that were not significantly lower than those of patients with a reduced ejection fraction, with or without adjustment for clinical differences between the two groups. Multivariate analysis showed that many of the predictors of death among patients with a preserved ejection fraction were similar to those for patients with a reduced ejection fraction, as described in previous studies.22
The data from other studies of patients with heart failure with a preserved ejection fraction have been inconsistent with respect to mortality and readmission rates.6,19,23,24 Some reports have estimated the annual mortality rate among patients with heart failure with a preserved ejection fraction to be in the range of 5 to 8 percent and have concluded that this entity is not as ominous as heart failure with a reduced ejection fraction.23 In contrast, Senni and Redfield reviewed 13 smaller studies examining the outcomes of patients with heart failure and found that 6 of the 13 studies did not show a significant difference in mortality between the two conditions.19 Another, larger single-center study by Varadarajan and Pai12 actually found a higher mortality rate among patients with heart failure with a preserved ejection fraction, although there were limitations to this analysis.23 More recent large clinical studies, such as the Danish Investigators of Arrhythmia and Mortality on Dofetilide–Congestive Heart Failure (DIAMOND–CHF) registry, the Euro Heart Failure survey, and the Management to Improve Survival in Congestive Heart Failure (MISCHF) study, all found lower relative mortality rates among those with heart failure with a preserved ejection fraction, but a high absolute mortality rate in this group, ranging from 10 percent at 12 weeks to 17 percent at 1 year.21,25,26
All these previous studies had several limitations. The majority of the subjects were clinic-based or referral patients. Among hospitalized patients, some were not admitted for heart failure, but heart failure developed after admission. In addition, these reports typically did not use an objective system for the classification of heart failure. In contrast, our study included only patients who were admitted with their first episode of heart failure, and we required all subjects to meet the Framingham criteria for heart failure. Thus, our study can be seen as an assessment of the clinical course of heart failure with a preserved ejection fraction as compared with that of heart failure with a reduced ejection fraction from the same point in the evolution of the disease.
The prognosis of heart failure with a preserved ejection fraction has also been evaluated in a few clinical trials, the largest of which were the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) trials. These studies also found a large difference in mortality between patients with preserved ejection fraction and those with reduced ejection fraction, but the patients enrolled in the CHARM-Preserved trial were significantly younger than those in our study (average age, 67 vs. 75 years), were predominantly male, and were more heterogeneous.27,28 They were thus enrolled at different points in their disease and represented a different study population than those traditionally thought to have heart failure with a preserved ejection fraction.
Our study had several limitations. Of the potentially eligible patients, only 42 percent had a documented assessment of left ventricular function at the time of admission to the hospital. Other studies have shown variation in the rates of assessment of ejection fraction in patients with heart failure.29-31 This may have resulted in a selection bias; several other studies have shown that physicians paradoxically tend to refer patients who are younger and less sick for investigations such as assessment of left ventricular function or angiography.29,32 Thus, we may have underestimated the actual risk of complications and death among patients with heart failure with a preserved ejection fraction, who tend to be older women with coexisting conditions.
In addition, the assessment of ejection fraction could not be standardized, and therefore, there may have been variations among different operators and different techniques that resulted in the misclassification of some patients. We excluded the group with a borderline ejection fraction (40 to 50 percent) in order to minimize the effects of misclassification. We included only patients whose ejection fraction had been assessed on admission, and although there has been concern that left ventricular function may become transiently impaired in patients presenting with pulmonary edema, this concern has not been substantiated in longitudinal follow-up studies.33
Restricting our analysis to patients hospitalized with a primary discharge diagnosis of heart failure presumably resulted in a more homogeneous study population than those in previous reports. However, we could not control for the decision-making process that led to the admission of a patient, and it is conceivable that for a given symptom severity, physicians are less likely to admit a patient who has a normal ejection fraction. Our data regarding symptom frequency are reassuring in this respect, but they do not entirely exclude the possibility that our group of patients with a preserved ejection fraction had to meet a higher admission standard. Finally, some patients may not have received a discharge diagnosis of heart failure once their ejection fraction was known to be normal, even though their symptoms and signs were consistent with the presence of heart failure; such an ascertainment bias could also have reduced the number of patients with “mild” heart failure with a preserved ejection fraction included in the cohort.
In summary, we determined the clinical features and outcomes of a large, population-based cohort of patients with heart failure with a preserved ejection fraction. Our study differs from others by including only patients admitted with confirmed heart failure and by including patients from small and large community hospitals as well as academic teaching institutions. In our analysis, approximately one third of patients admitted with heart failure had an ejection fraction of more than 50 percent, and such patients could not be reliably distinguished from those with an ejection fraction of less than 40 percent on clinical grounds. The in-hospital complication rates of the two groups were similar. The adjusted one-year mortality rate among patients with heart failure with a reduced ejection fraction was similar to that of patients with a preserved ejection fraction; the morbidity rates in the two groups were similar; and the absolute mortality rate among patients with heart failure with a preserved ejection fraction was higher than previously reported values.
Supported by grants from the Heart and Stroke Foundation of Ontario, the Canadian Institutes of Health Research, the Canadian Heart Failure Network of Exploratory Teams, and the Canadian Cardiovascular Outcomes Research Team.
No potential conflict of interest relevant to this article was reported.
Drs. Tu and Liu contributed equally to this article.
Source Information
From the Heart & Stroke/Richard Lewar Centre of Excellence, University of Toronto, and the Division of Cardiology, Toronto General Hospital, University Health Network (R.S.B., J.V.T., D.S.L., A.H., P.P.L.); the Division of General Internal Medicine, Sunnybrook and Women's College Health Sciences Centre, University of Toronto (R.S.B., J.V.T.); and the Institute for Clinical Evaluative Sciences (J.V.T., D.S.L., P.C.A., J.F., Y.G.) — all in Toronto; and the National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, Mass. (D.S.L.).
Address reprint requests to Dr. Liu at the Heart & Stroke/Richard Lewar Centre of Excellence, NCSB 11-1266, Toronto General Hospital, 200 Elizabeth St., Toronto, ON M5G 2C4, Canada, or at peter.liu@utoronto.ca.
- References
References
1
Hunt SA ,Abraham WT ,Chin MH , et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235
CrossRef | Web of Science | Medline2
Kitzman DW ,Gardin JM ,Gottdiener JS , et al. Importance of heart failure with preserved systolic function in patients > or = 65 years of age. Am J Cardiol 2001;87:413-419
CrossRef | Web of Science | Medline3
Redfield MM ,Jacobsen SJ ,Burnett JC Jr ,Mahoney DW ,Bailey KR ,Rodeheffer RJ . Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003;289:194-202
CrossRef | Web of Science | Medline4
Vasan RS ,Levy D . Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation 2000;101:2118-2121
Web of Science | Medline5
Zile MR ,Gaasch WH ,Carroll JD , et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001;104:779-782
CrossRef | Web of Science | Medline6
Cohn JN ,Johnson G . Heart failure with normal ejection fraction: the V-HeFT Study. Circulation 1990;81:Suppl III:III-48
CrossRef7
Vasan RS ,Benjamin EJ ,Levy D . Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol 1995;26:1565-1574
CrossRef | Web of Science | Medline8
Masoudi FA ,Havranek EP ,Smith G , et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 2003;41:217-223
CrossRef | Web of Science | Medline9
Smith GL ,Masoudi FA ,Vaccarino V ,Radford MJ ,Krumholz HM . Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 2003;41:1510-1518
CrossRef | Web of Science | Medline10
Vasan RS ,Larson MG ,Benjamin EJ ,Evans JC ,Reiss CK ,Levy D . Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol 1999;33:1948-1955
CrossRef | Web of Science | Medline11
Kitzman DW . Diastolic heart failure in the elderly. Heart Fail Rev 2002;7:17-27
CrossRef | Medline12
Varadarajan P ,Pai RG . Prognosis of congestive heart failure in patients with normal versus reduced ejection fractions: results from a cohort of 2,258 hospitalized patients. J Card Fail 2003;9:107-112
CrossRef | Web of Science | Medline13
Pernenkil R ,Vinson JM ,Shah AS ,Beckham V ,Wittenberg C ,Rich MW . Course and prognosis in patients > or = 70 years of age with congestive heart failure and normal versus abnormal left ventricular ejection fraction. Am J Cardiol 1997;79:216-219
CrossRef | Web of Science | Medline14
Setaro JF ,Soufer R ,Remetz MS ,Perlmutter RA ,Zaret BL . Long-term outcome in patients with congestive heart failure and intact systolic left ventricular performance. Am J Cardiol 1992;69:1212-1216
CrossRef | Web of Science | Medline15
Lee DS ,Austin PC ,Rouleau JL ,Liu PP ,Naimark D ,Tu JV . Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA 2003;290:2581-2587
CrossRef | Web of Science | Medline16
Jong P ,Vowinckel E ,Liu PP ,Gong Y ,Tu JV . Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002;162:1689-1694
CrossRef | Web of Science | Medline17
Department of Health and Human Services. International classification of diseases, 9th rev., clinical modification: ICD-9-CM. Washington, D.C.: Government Printing Office, 1988.
18
Senni M ,Tribouilloy CM ,Rodeheffer RJ , et al. Congestive heart failure in the community. Circulation 1998;98:2282-2289
Web of Science | Medline19
Senni M ,Redfield MM . Heart failure with preserved systolic function: a different natural history? J Am Coll Cardiol 2001;38:1277-1282
CrossRef | Web of Science | Medline20
Fuster V ,Ryden LE ,Asinger RW , et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 2001;38:1231-1266
CrossRef | Web of Science | Medline21
Maisel AS ,McCord J ,Nowak RM , et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 2003;41:2010-2017
CrossRef | Web of Science | Medline22
Lenzen MJ ,Scholte op Reimer WJ ,Boersma E , et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 2004;25:1214-1220
CrossRef | Web of Science | Medline23
Aurigemma GP ,Gaasch WH . Diastolic heart failure. N Engl J Med 2004;351:1097-1105
Full Text | Web of Science | Medline24
Jones RC ,Francis GS ,Lauer MS . Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 2004;44:1025-1029
CrossRef | Web of Science | Medline25
Gustafsson F ,Torp-Pedersen C ,Brendorp B ,Seibaek M ,Burchardt H ,Kober L . Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 2003;24:863-870
CrossRef | Web of Science | Medline26
Philbin EF ,Rocco TA Jr ,Lindenmuth NW ,Ulrich K ,Jenkins PL . Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors. Am J Med 2000;109:605-613
CrossRef | Web of Science | Medline27
McMurray JJ ,Ostergren J ,Swedberg K , et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362:767-771
CrossRef | Web of Science | Medline28
Yusuf S ,Pfeffer MA ,Swedberg K , et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003;362:777-781
CrossRef | Web of Science | Medline29
Ko D ,Tu JV ,Masoudi FA , et al. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med 2005;165:2486-2492
CrossRef | Web of Science | Medline30
Hernandez AF ,Velazquez EJ ,Solomon SD , et al. Left ventricular assessment in myocardial infarction: the VALIANT registry. Arch Intern Med 2005;165:2162-2169
CrossRef | Web of Science | Medline31
Steg PG ,Dabbous OH ,Feldman LJ , et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation 2004;109:494-499
CrossRef | Web of Science | Medline32
Krumholz HM ,Wang Y ,Parent EM ,Mockalis J ,Petrillo M ,Radford MJ . Quality of care for elderly patients hospitalized with heart failure. Arch Intern Med 1997;157:2242-2247
CrossRef | Web of Science | Medline33
Gandhi SK ,Powers JC ,Nomeir AM , et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001;344:17-22
Full Text | Web of Science | Medline
- Citing Articles (321)
Citing Articles
1
C. M. Carlsen, M. Bay, V. Kirk, J. P. Gotze, L. Kober, O. W. Nielsen. (2012) Prevalence and prognosis of heart failure with preserved ejection fraction and elevated N-terminal pro brain natriuretic peptide: a 10-year analysis from the Copenhagen Hospital Heart Failure Study. European Journal of Heart Failure
CrossRef2
Yoichi Takaya, Manabu Taniguchi, Motoaki Sugawara, Saori Nobusada, Kengo Kusano, Teiji Akagi, Hiroshi Ito. (2012) Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction. Heart and Vessels
CrossRef3
Christine C. Welles, Ivy A. Ku, Damon M. Kwan, Mary A. Whooley, Nelson B. Schiller, Mintu P. Turakhia. (2012) Left Atrial Function Predicts Heart Failure Hospitalization in Subjects With Preserved Ejection Fraction and Coronary Heart Disease. Journal of the American College of Cardiology 59:7, 673-680
CrossRef4
Eduardo Delgado Parada, Francisco Manuel Suárez García, Virgina López Gaona, Solange Gutiérrez Vara, Juan Jose Solano Jaurrieta. (2012) Mortality and functional evolution at one year after hospital admission due to heart failure (HF) in elderly patients. Archives of Gerontology and Geriatrics 54:1, 261-265
CrossRef5
Goran Loncar, Stephan von Haehling, Elvis Tahirovic, Simone Inkrot, Meinhard Mende, Nikola Sekularac, Mitja Lainscak, Svetlana Apostolovic, Biljana Putnikovic, Frank Edelmann, Rolf Wachter, Sinisa Dimkovic, Finn Waagstein, Götz Gelbrich, Hans-Dirk Düngen. (2012) Effect of beta blockade on natriuretic peptides and copeptin in elderly patients with heart failure and preserved or reduced ejection fraction: Results from the CIBIS-ELD trial. Clinical Biochemistry 45:1-2, 117-122
CrossRef6
Richa Agarwal, Sanjiv J. Shah, Aimee J. Foreman, Cherylanne Glassner, Sonja D. Bartolome, Zeenat Safdar, Sandra L. Coslet, Allen S. Anderson, Mardi Gomberg-Maitland. (2012) Risk Assessment in Pulmonary Hypertension Associated with Heart Failure and Preserved Ejection Fraction. The Journal of Heart and Lung Transplantation
CrossRef7
G.C. Fernández-Pérez, R. Duarte, M. Corral de la Calle, J. Calatayud, J. Sánchez González. (2012) Análisis de la función diastólica del ventrículo izquierdo mediante resonancia magnética. Radiología
CrossRef8
Hajime Satomura, Hiroshi Wada, Kenichi Sakakura, Norifumi Kubo, Nahoko Ikeda, Yoshitaka Sugawara, Junya Ako, Shin-ichi Momomura. (2012) Congestive heart failure in the elderly: Comparison between reduced ejection fraction and preserved ejection fraction. Journal of Cardiology
CrossRef9
Scott D. Solomon. (2012) Vasodilators Across the Heart Failure Spectrum. Journal of the American College of Cardiology 59:5, 452-454
CrossRef10
Bradley D. Hayley, Ian G. Burwash. (2012) Heart failure with normal left ventricular ejection fraction. Current Opinion in Cardiology1
CrossRef11
Andrew L. Clark. (2011) Almanac 2011: heart failure. The national society journals present selected research that has driven recent advances in clinical cardiology. Revista Portuguesa de Cardiologia 30:12, 941-948
CrossRef12
Andrew L. Clark. (2011) Almanac 2011: heart failure. The national society journals present selected research that has driven recent advances in clinical cardiology. Revista Portuguesa de Cardiologia (English Edition) 30:12, 941-948
CrossRef13
Smita I. Negi, Euy-Myoung Jeong, Irfan Shukrullah, Mihai Raicu, Samuel C. Dudley Jr. (2011) Association of Low Plasma Adiponectin With Early Diastolic Dysfunction. Congestive Heart Failureno-no
CrossRef14
G. Mahadevan, G. Dwivedi, L. Williams, R. P. Steeds, M. Frenneaux. (2011) Epidemiology and diagnosis of heart failure with preserved left ventricular ejection fraction: rationale and design of the study. European Journal of Heart Failure
CrossRef15
Apurva O. Badheka, Ankit Rathod, Mohammad A. Kizilbash, Aditya Bhardwaj, Omaima Ali, Luis Afonso, Sony Jacob. (2011) Comparison of Mortality and Morbidity in Patients With Atrial Fibrillation and Heart Failure With Preserved Versus Decreased Left Ventricular Ejection Fraction. The American Journal of Cardiology 108:9, 1283-1288
CrossRef16
Otilia Buiciuc, Dan Rusinaru, Franck Lévy, Marcel Peltier, Michel Slama, Laurent Leborgne, Christophe Tribouilloy. (2011) Low Systolic Blood Pressure at Admission Predicts Long-Term Mortality in Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure 17:11, 907-915
CrossRef17
José A. Magaña-Serrano, Wael Almahmeed, Efrain Gomez, Mostafa Al-Shamiri, Djamila Adgar, Philippe Sosner, Daniel Herpin. (2011) Prevalence of Heart Failure With Preserved Ejection Fraction in Latin American, Middle Eastern, and North African Regions in the I PREFER Study (Identification of Patients With Heart Failure and PREserved Systolic Function: An Epidemiological Regional Study). The American Journal of Cardiology 108:9, 1289-1296
CrossRef18
Alexander Burashnikov, Charles Antzelevitch. (2011) Ranolazine versus amiodarone for prevention of postoperative atrial fibrillation. Future Cardiology 7:6, 733-737
CrossRef19
Christophe Meune, Lara Khouzami, Karim Wahbi, Philippe Caramelle, Valérie Decostre, Gisèle Bonne, Françoise Pecker. (2011) Blood glutathione decrease in subjects carrying lamin A/C gene mutations is an early marker of cardiac involvement. Neuromuscular Disorders
CrossRef20
Claudio Ronco. (2011) Cardio-renal syndromes: from foggy bottoms to sunny hills. Heart Failure Reviews 16:6, 509-517
CrossRef21
Dawn C. Scantlebury, Barry A. Borlaug. (2011) Why are women more likely than men to develop heart failure with preserved ejection fraction?. Current Opinion in Cardiology 26:6, 562-568
CrossRef22
Yan Zhang, Meredith L. Kilgore, Tarun Arora, Marjan Mujib, O. James Ekundayo, Inmaculada B. Aban, Margaret A. Feller, Ravi V. Desai, Thomas E. Love, Richard M. Allman, Gregg C. Fonarow, Ali Ahmed. (2011) Design and rationale of studies of neurohormonal blockade and outcomes in diastolic heart failure using OPTIMIZE-HF registry linked to Medicare data. International Journal of Cardiology
CrossRef23
Jassim Al Suwaidi, Awad Al-Qahtani, Nidal Asaad, Abdul Wahid Al-Mulla, Rajivir Singh, Hajar A. AlBinali. (2011) Comparison of Women Versus Men Hospitalized With Heart Failure (from a 20-Year Registry in a Middle-Eastern Country 1991–2010). The American Journal of Cardiology
CrossRef24
Simon de Denus, Joël Lavoie, Anique Ducharme, Eileen O'Meara, Normand Racine, Martin G. Sirois, Paul-Eduard Neagoe, Li Zhu, Jean-Lucien Rouleau, Michel White. (2011) Differences in Biomarkers in Patients With Heart Failure With a Reduced vs a Preserved Left Ventricular Ejection Fraction. Canadian Journal of Cardiology
CrossRef25
Chaudhary Ketul R, El-Sikhry Haitham, Seubert John M. (2011) Mitochondria and the aging heart. Journal of Geriatric Cardiology 8:3, 159-167
CrossRef26
Nicoletta Riva, Gregory YH Lip. (2011) Nebivolol for the treatment of heart failure. Expert Opinion on Investigational Drugs1-14
CrossRef27
G. C. M. Linssen, M. Rienstra, T. Jaarsma, A. A. Voors, I. C. van Gelder, H. L. Hillege, D. J. van Veldhuisen. (2011) Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. European Journal of Heart Failure 13:10, 1111-1120
CrossRef28
Zhongwei Cheng, Kongbo Zhu, Taibo Chen, Peng Gao, Kang’an Cheng, Ligang Fang, Hua Deng, Wenling Zhu, Quan Fang. (2011) Poor Prognosis in Chronic Heart Failure Patients With Reduced Ejection Fraction in China. Congestive Heart Failureno-no
CrossRef29
Frank Edelmann, Götz Gelbrich, Hans-Dirk Düngen, Stefan Fröhling, Rolf Wachter, Raoul Stahrenberg, Lutz Binder, Agnieszka Töpper, Diana Jahandar Lashki, Silja Schwarz, Christoph Herrmann-Lingen, Markus Löffler, Gerd Hasenfuss, Martin Halle, Burkert Pieske. (2011) Exercise Training Improves Exercise Capacity and Diastolic Function in Patients With Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology 58:17, 1780-1791
CrossRef30
R. Pecini, J. J. Thune, C. Torp-Pedersen, C. Hassager, L. Kober. (2011) The relationship between mitral regurgitation and ejection fraction as predictors for the prognosis of patients with heart failure. European Journal of Heart Failure 13:10, 1121-1125
CrossRef31
D. Burkhoff. (2011) Mortality in heart failure with preserved ejection fraction: an unacceptably high rate. European Heart Journal
CrossRef32
István Késői, Balázs Sági, Tibor Vas, Tünde Pintér, Tibor Kovács, István Wittmann, Judit Nagy. (2011) Cardiorenalis szindrómák. Orvosi Hetilap 152:38, 1520-1527
CrossRef33
J.-J. Perrenoud. (2011) Heart Failure (Part 2). European Geriatric Medicine 2:4, 237-244
CrossRef34
Sarwat I. Chaudhry, Gail McAvay, Yuming Ning, Heather G. Allore, Anne B. Newman, Thomas M. Gill. (2011) Risk Factors for Onset of Disability Among Older Persons Newly Diagnosed With Heart Failure: The Cardiovascular Health Study. Journal of Cardiac Failure 17:9, 764-770
CrossRef35
Sujit Rajagopalan, Anjuman Arora, Nusrat Shafiq, Srinivas Reddy S, Promila Pandhi, Niti Mittal, Samir Malhotra. (2011) Pharmacotherapy of heart failure with normal ejection fraction (HFNEF) - a systematic review. British Journal of Clinical Pharmacology 72:3, 369-380
CrossRef36
Gavin Y. Oudit, Josef M. Penninger. (2011) Recombinant Human Angiotensin-Converting Enzyme 2 as a New Renin-Angiotensin System Peptidase for Heart Failure Therapy. Current Heart Failure Reports 8:3, 176-183
CrossRef37
, C. Berry, R. N. Doughty, C. Granger, L. Kober, B. Massie, F. McAlister, J. McMurray, S. Pocock, K. Poppe, K. Swedberg, J. Somaratne, G. A. Whalley, A. Ahmed, B. Andersson, A. Bayes-Genis, C. Berry, M. Cowie, R. Cubbon, R. N. Doughty, J. Ezekowitz, J. Gonzalez-Juanatey, M. Gorini, I. Gotsman, L. Grigorian-Shamagian, M. Guazzi, M. Kearney, L. Kober, M. Komajda, A. di Lenarda, M. Lenzen, D. Lucci, S. Macin, B. Madsen, A. Maggioni, M. Martinez-Selles, F. McAlister, F. Oliva, K. Poppe, M. Rich, M. Richards, M. Senni, I. Squire, G. Taffet, L. Tarantini, C. Tribouilloy, R. Troughton, H. Tsutsui, G. A. Whalley, R. N. Doughty, N. Earle, K. Perera, K. Poppe, G. A. Whalley, J. Dobson, S. Pocock, K. Poppe, R. N. Doughty, G. Whalley, B. Andersson, C. Hall, A. M. Richards, R. Troughton, J. Lainchbury, C. Berry, K. Hogg, J. Norrie, K. Stevenson, M. Brett, J. McMurray, M. A. Pfeffer, K. Swedberg, C. B. Granger, P. Held, J. J. V. McMurray, E. L. Michelson, B. Olofsson, J. Ostergren, S. Yusuf, L. Kober, C. Torp-Pedersen, A. Ahmed, M. J. Lenzen, W. J. M. Scholte op Reimer, E. Boersma, P. J. M. J. Vantrimpont, F. Follath, K. Swedberg, J. Cleland, M. Komajda, I. Gotsman, D. Zwas, D. Planer, T. Azaz-Livshits, D. Admon, C. Lotan, A. Keren, L. Grigorian-Shamagian, A. Varela-Roman, P. Mazon-Ramos, P. Rigeiro-Veloso, M. A. Bandin-Dieguez, J. R. Gonzalez-Juanatey, M. Guazzi, J. Myers, R. Arena, F. A. McAlister, J. Ezekowitz, P. W. Armstrong, B. Cujec, I. Paterson, M. R. Cowie, D. A. Wood, A. J. S. Coats, S. G. Thompson, V. Suresh, P. A. Poole-Wilson, G. C. Sutton, M. Martinez-Selles, J. A. G. Robles, L. Prieto, M. D. Munoa, E. Frades, O. Diaz-Castro, J. Almendral, L. Tarantini, P. Faggiano, M. Senni, D. Lucci, D. Bertoli, M. Porcu, C. Opasich, L. Tavazzi, A. P. Maggioni, V. Kirk, M. Bay, J. Parner, K. Krogsgaard, T. M. Herzog, S. Boesgaard, C. Hassager, O. W. Nielsen, J. Aldershvile, H. Nielsen, L. Kober, S. M. Macin, E. R. Perna, J. P. Cimbaro Canella, P. Alvarenga, R. Pantich, N. Rios, E. F. Farias, J. R. Badaracco, B. K. Madsen, J. F. Hansen, K. H. Stokholm, J. Brons, D. Husum, L. S. Mortensen, A. Bayes-Genis, R. Vazquez, T. Puig, C. Fernandez-Palomeque, A. Bardaji, D. Pascual-Figal, J. Ordonez-Llanos, M. Valdes, A. Gabarrus, R. Pavon, L. Pastor, J. R. Gonzalez-Juanatey, J. Almendral, M. Fiol, V. Nieto, C. Macaya, J. Cinca, A. Bayes de Luna, J. D. Newton, H. M. Blackledge, I. B. Squire, S. P. Wright, G. A. Whalley, R. N. Doughty, R. Kerzner, B. F. Gage, K. E. Freedland, M. W. Rich, B. C. Huynh, A. Rovner, K. E. Freedland, R. M. Carney, M. W. Rich, G. E. Taffet, T. A. Teasdale, A. J. Bleyer, N. J. Kutka, R. J. L. Tribouilloy, D. Rusinaru, H. Mahjoub, V. Souliere, F. Levy, M. Peltier, H. Tsutsui, M. Tsuchihashi, A. Takeshita, P. A. MacCarthy, M. T. Kearney, R. Cubbon, J. Nolan, A. J. Lee, R. J. Prescott, A. M. Shah, W. P. Brooksby, K. A. A. Fox, A. Varela-Roman, J. R. Gonzalez-Juanatey, P. Basante, R. Trillo, J. Garcia-Seara, J. L. Martinez-Sande, F. Gude. (2011) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. European Heart Journal
CrossRef38
Ken Kaila, Mark J. Haykowsky, Richard B. Thompson, D. Ian Paterson. (2011) Heart failure with preserved ejection fraction in the elderly: scope of the problem. Heart Failure Reviews
CrossRef39
Robert Neil Doughty. (2011) Prognosis for Patients With Heart Failure With Preserved Ejection Fraction. Is It the Same As Low Ejection Fraction?. Revista Española de Cardiología (English Edition) 64:8, 646-648
CrossRef40
Robert Neil Doughty. (2011) Pronóstico de los pacientes con insuficiencia cardiaca y fracción de eyección preservada. ¿Es el mismo que con fracción de eyección baja?. Revista Española de Cardiología 64:8, 646-648
CrossRef41
A. E. Frost. (2011) The other pulmonary hypertension: heart failure with preserved ejection fraction. International Journal of Clinical Practice 65, 3-5
CrossRef42
Aaron M. From, Barry A. Borlaug. (2011) Heart Failure with Preserved Ejection Fraction: Pathophysiology and Emerging Therapies. Cardiovascular Therapeutics 29:4, e6-e21
CrossRef43
Leon A. Cannizzaro, Jonathan P. Piccini, Uptal D. Patel, Adrian F. Hernandez. (2011) Device Therapy in Heart Failure Patients With Chronic Kidney Disease. Journal of the American College of Cardiology 58:9, 889-896
CrossRef44
J. Meluzin, J. Sitar, J. Kristek, R. Prosecky, M. Pesl, H. Podrouzkova, V. Soska, R. Panovsky, L. Dusek. (2011) The role of exercise echocardiography in the diagnostics of heart failure with normal left ventricular ejection fraction. European Journal of Echocardiography 12:8, 591-602
CrossRef45
Hitesh Patel, Baris A. Ozdemir, Mitesh Patel, Han B. Xiao, Philip A. Poole-Wilson, Stuart D. Rosen. (2011) Impairment of autonomic reactivity is a feature of heart failure whether or not the left ventricular ejection fraction is normal. International Journal of Cardiology 151:1, 34-39
CrossRef46
Nobuyuki Shiba, Hiroaki Shimokawa. (2011) Prospective care of heart failure in Japan: lessons from CHART studies. The EPMA Journal
CrossRef47
Jing Yan, Shi-Jin Gong, Li Li, Hai-Yan Yu, Hai-Wen Dai, Jin Chen, Cheng-Wu Tan, Qiang-Hong Xv, Guo-Long Cai. (2011) Combination of B-type natriuretic peptide and minute ventilation/carbon dioxide production slope improves risk stratification in patients with diastolic heart failure. International Journal of Cardiology
CrossRef48
Dmitry Abramov, Kun-Lun He, Jie Wang, Daniel Burkhoff, Mathew S. Maurer. (2011) The Impact of Extra Cardiac Comorbidities on Pressure Volume Relations in Heart Failure and Preserved Ejection Fraction. Journal of Cardiac Failure 17:7, 547-555
CrossRef49
Thanh T. Phan, Ganesh Nallur Shivu, Khalid Abozguia, John E. Sanderson, Michael Frenneaux. (2011) The pathophysiology of heart failure with preserved ejection fraction: From molecular mechanisms to exercise haemodynamics. International Journal of Cardiology
CrossRef50
X.-X. Shuai, Y.-Y. Chen, Y.-X. Lu, G.-H. Su, Y.-H. Wang, H.-L. Zhao, J. Han. (2011) Diagnosis of heart failure with preserved ejection fraction: which parameters and diagnostic strategies are more valuable?. European Journal of Heart Failure 13:7, 737-745
CrossRef51
Claudius Jacobshagen, Luiz Belardinelli, Gerd Hasenfuss, Lars S. Maier. (2011) Ranolazine for the Treatment of Heart Failure With Preserved Ejection Fraction: Background, Aims, and Design of the RALI-DHF Study. Clinical Cardiology 34:7, 426-432
CrossRef52
Qian Li, Robert J. Glynn, Nancy A. Dreyer, Jun Liu, Helen Mogun, Soko Setoguchi. (2011) Validity of claims-based definitions of left ventricular systolic dysfunction in Medicare patients. Pharmacoepidemiology and Drug Safety 20:7, 700-708
CrossRef53
Leanne Groban, Sarah Lindsey, Hao Wang, Marina S. Lin, Kimberly A. Kassik, Frederico S. M. Machado, Christy S. Carter. (2011) Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 × Brown Norway male rats. AGE
CrossRef54
Gregory Giamouzis, Javed Butler, Filippos Triposkiadis. (2011) Renal Function in Advanced Heart Failure. Congestive Heart Failure 17:4, 180-188
CrossRef55
Kamran A. Shaikh, Miguel A. Quinones. (2011) The diastolic stress test: a new approach to an old problem. Heart Failure Reviews 16:4, 339-349
CrossRef56
Jolanda Velden. (2011) Diastolic myofilament dysfunction in the failing human heart. Pflügers Archiv - European Journal of Physiology 462:1, 155-163
CrossRef57
Wang Wang, Sreedhar Bodiga, Subhash K. Das, Jennifer Lo, Vaibhav Patel, Gavin Y. Oudit. (2011) Role of ACE2 in diastolic and systolic heart failure. Heart Failure Reviews
CrossRef58
Raúl Quirós López, Javier García Alegría, María Dolores Martín Escalante, Javier Trujillo Santos, María Ángeles Villena Ruiz, Emilio Perea Milla. (2011) Factores pronósticos y supervivencia a largo plazo tras el diagnóstico inicial de insuficiencia cardiaca. Medicina Clínica
CrossRef59
Redi Pecini, Daniel Vega Møller, Christian Torp-Pedersen, Christian Hassager, Lars Køber. (2011) Heart failure etiology impacts survival of patients with heart failure. International Journal of Cardiology 149:2, 211-215
CrossRef60
Johannes Soma. (2011) Heart failure with preserved left ventricular ejection fraction: Concepts, misconceptions and future directions. Blood Pressure 20:3, 129-133
CrossRef61
S. Reda, L.J. Motloch, U.C. Hoppe. (2011) Herzinsuffizienz mit erhaltener Pumpfunktion. Der Kardiologe 5:3, 237-244
CrossRef62
Jiri Karasek, Petr Widimsky, Petr Ostadal, Hana Hrabakova, Martin Penicka. (2011) Acute heart failure registry from high-volume university hospital ED: comparing European and US data. The American Journal of Emergency Medicine
CrossRef63
G. O. Oghlakian, I. Sipahi, J. C. Fang. (2011) Treatment of Heart Failure With Preserved Ejection Fraction: Have We Been Pursuing the Wrong Paradigm?. Mayo Clinic Proceedings 86:6, 531-539
CrossRef64
Samuel Unzek, Zoran B. Popovic, Thomas H. Marwick. (2011) Effect of Recommendations on Interobserver Consistency of Diastolic Function Evaluation. JACC: Cardiovascular Imaging 4:5, 460-467
CrossRef65
Philip Wood, Sanaz Piran, Peter P. Liu. (2011) Diastolic Heart Failure: Progress, Treatment Challenges, and Prevention. Canadian Journal of Cardiology 27:3, 302-310
CrossRef66
Mario Kasner, Regina Gaub, Dirk Westermann, Hilmi Kaplan, Susan Akpulat, Paul Steendijk, Heinz-Peter Schultheiss, Carsten Tschöpe. (2011) Simultaneous estimation of NT-proBNP on top to mitral flow Doppler echocardiography as an accurate strategy to diagnose diastolic dysfunction in HFNEF. International Journal of Cardiology 149:1, 23-29
CrossRef67
S Setoguchi, W H Shrank, J Liu, JC Lee, U Saya, W C Winkelmayer, N A Dreyer. (2011) Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: Challenges in Comparative Effectiveness Using Medicare Data. Clinical Pharmacology & Therapeutics 89:5, 674-682
CrossRef68
J.-K. Lee, H.-H. Lin, C.-T. Tsai, J.-J. Chen, C.-C. Kuo, Y.-C. Lien, J.-W. Lin, J.-W. Huang, S.-W. Hwang, J.-J. Hwang, C.-D. Tseng, F.-T. Chiang, J.-J. Chen, C.-K. Wu. (2011) Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutrition, Metabolism and Cardiovascular Diseases
CrossRef69
Shahnaz Punjani, Wen-Chih Wu, Scott Cohen, Satish C. Sharma, Gaurav Choudhary. (2011) Echocardiographic Indices of Diastolic Function Relate to Functional Capacity and Quality of Life in Ambulatory Men with Atrial Fibrillation. Journal of the American Society of Echocardiography 24:5, 533-540.e3
CrossRef70
Shashank S Sinha, Richard P Shannon. (2011) Insulin resistance and progression of heart failure in the older adult. Aging Health 7:2, 297-309
CrossRef71
David J. Holland, Dharam J. Kumbhani, Salim H. Ahmed, Thomas H. Marwick. (2011) Effects of Treatment on Exercise Tolerance, Cardiac Function, and Mortality in Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology 57:16, 1676-1686
CrossRef72
Sameer Ather, Wenyaw Chan, Annirudha Chillar, David Aguilar, Allison M. Pritchett, Kumudha Ramasubbu, Xander H.T. Wehrens, Anita Deswal, Biykem Bozkurt. (2011) Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: A complex relationship. American Heart Journal 161:3, 567-573
CrossRef73
Carlo Nozzoli, Giovanni Mathieu, Gianfranco Gensini. (2011) BPCO e scompenso cardiaco. Italian Journal of Medicine 5:1, 22-37
CrossRef74
D. H. MacIver. (2011) A new method for quantification of left ventricular systolic function using a corrected ejection fraction. European Journal of Echocardiography 12:3, 228-234
CrossRef75
Megan M Barnes, Michael P Dorsch, Scott L Hummel, Todd M Koelling, Barry E Bleske. (2011) Treatment of Heart Failure with Preserved Ejection Fraction. Pharmacotherapy 31:3, 312-331
CrossRef76
Felicia N. Williams, David N. Herndon, Oscar E. Suman, Jong O. Lee, William B. Norbury, Ludwik K. Branski, Ronald P. Mlcak, Marc G. Jeschke. (2011) Changes in Cardiac Physiology After Severe Burn Injury. Journal of Burn Care & Research 32:2, 269-274
CrossRef77
Mark J. Boogers, Jacob M. van Werkhoven, Joanne D. Schuijf, Victoria Delgado, Heba M. El-Naggar, Eric Boersma, Gaetano Nucifora, Rob J. van der Geest, Bernard P. Paelinck, Lucia J. Kroft, Johan H.C. Reiber, Albert de Roos, Jeroen J. Bax, Hildo J. Lamb. (2011) Feasibility of Diastolic Function Assessment With Cardiac CT. JACC: Cardiovascular Imaging 4:3, 246-256
CrossRef78
E. Carluccio, P. Biagioli, G. Alunni, A. Murrone, V. Leonelli, P. Pantano, E. Biscottini, W. J. Paulus, G. Ambrosio. (2011) Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction. European Journal of Heart Failure 13:3, 292-302
CrossRef79
Erin Y. Tjam, George A. Heckman, Stuart Smith, Bruce Arai, John Hirdes, Jeff Poss, Robert S. McKelvie. (2011) Predicting heart failure mortality in frail seniors: Comparing the NYHA functional classification with the Resident Assessment Instrument (RAI) 2.0
. International Journal of Cardiology
CrossRef80
Stefano Muzzarelli, Karen Ordovas, Charles B. Higgins. (2011) Cardiovascular MRI for the assessment of heart failure: Focus on clinical management and prognosis. Journal of Magnetic Resonance Imaging 33:2, 275-286
CrossRef81
Mario Kasner, Dirk Westermann, Begoña Lopez, Regina Gaub, Felicitas Escher, Uwe Kühl, Heinz-Peter Schultheiss, Carsten Tschöpe. (2011) Diastolic Tissue Doppler Indexes Correlate With the Degree of Collagen Expression and Cross-Linking in Heart Failure and Normal Ejection Fraction. Journal of the American College of Cardiology 57:8, 977-985
CrossRef82
Suzan Willemsen, Jasper W. L. Hartog, M. Rebecca Heiner-Fokkema, Dirk J. Veldhuisen, Adriaan A. Voors. (2011) Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome. Heart Failure Reviews
CrossRef83
R. Serpi, A.-M. Tolonen, J. Huusko, J. Rysa, O. Tenhunen, S. Yla-Herttuala, H. Ruskoaho. (2011) Vascular endothelial growth factor-B gene transfer prevents angiotensin II-induced diastolic dysfunction via proliferation and capillary dilatation in rats. Cardiovascular Research 89:1, 204-213
CrossRef84
Giuseppe Cocco, Stefano Pandolfi. (2011) Physical Exercise With Weight Reduction Lowers Blood Pressure and Improves Abnormal Left Ventricular Relaxation in Pharmacologically Treated Hypertensive Patients. The Journal of Clinical Hypertension 13:1, 23-29
CrossRef85
Nobuyuki Shiba, Kotaro Nochioka, Masanobu Miura, Haruka Kohno, Hiroaki Shimokawa, . (2011) Trend of Westernization of Etiology and Clinical Characteristics of Heart Failure Patients in Japan. Circulation Journal 75:4, 823-833
CrossRef86
Claudio Ronco, Federico Ronco. (2011) Cardio-renal syndromes: a systematic approach for consensus definition and classification. Heart Failure Reviews
CrossRef87
Chiara Lazzeri, Serafina Valente, Roberto Tarquini, Gian Franco Gensini. (2011) Cardiorenal Syndrome Caused by Heart Failure with Preserved Ejection Fraction. International Journal of Nephrology 2011, 1-7
CrossRef88
Wilfried Dinh, Werner Nickl, Reiner Füth, Mark Lankisch, Georg Hess, Dietmar Zdunek, Thomas Scheffold, Michael Barroso, Klaus Tiroch, Dan Ziegler, Melchior Seyfarth. (2011) High sensitive troponin T and heart fatty acid binding protein: Novel biomarker in heart failure with normal ejection fraction?: A cross-sectional study. BMC Cardiovascular Disorders 11:1, 41
CrossRef89
Gautham Viswanathan, Scott Gilbert. (2011) The Cardiorenal Syndrome: Making the Connection. International Journal of Nephrology 2011, 1-10
CrossRef90
C. S. P. Lam, E. Donal, E. Kraigher-Krainer, R. S. Vasan. (2011) Epidemiology and clinical course of heart failure with preserved ejection fraction. European Journal of Heart Failure 13:1, 18-28
CrossRef91
João M. Silva, Amanda M. Ribas R. Oliveira, Juliano Lopes Segura, Marcel Henrique Ribeiro, Carolina Nacevicius Sposito, Diogo O. Toledo, Ederlon Rezende, Luiz M. Sá Malbouisson. (2011) A large Venous-Arterial PCO2 Is Associated with Poor Outcomes in Surgical Patients. Anesthesiology Research and Practice 2011, 1-8
CrossRef92
Anh L. Bui, Tamara B. Horwich, Gregg C. Fonarow. (2011) Epidemiology and risk profile of heart failure. Nature Reviews Cardiology 8:1, 30-41
CrossRef93
Francisco Javier Carrasco-Sánchez, Luis Galisteo-Almeda, Inmaculada Páez-Rubio, Francisco Javier Martínez-Marcos, Crescencio Camacho-Vázquez, Carlos Ruiz-Frutos, Emilio Pujol-De La Llave. (2011) Prognostic Value of Cystatin C on Admission in Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure 17:1, 31-38
CrossRef94
Alfried Germing, Michael Gotzmann, Tamara Schikowski, Andrea Vierkotter, Ulrich Ranft, Ursula Kramer, Andreas Mugge. (2011) High frequency of diastolic dysfunction in a population-based cohort of elderly women - but poor association with the symptom dyspnea. BMC Geriatrics 11:1, 71
CrossRef95
Takehiro Nakahara, Masahiro Jinzaki, Nobuaki Fukuda, Yasuyuki Takahashi, Toshihiro Ishihara, Atsuko Takada, Kenichi Suzuki, Mamoru Manita, Tetsurou Imanari, Norio Kanesawa, Sachio Kuribayashi, Masahiko Kurabayashi. (2011) Estimation of the left ventricular diastolic function with cardiac MDCT: Correlation of the slope of the time-enhancement-curve with the mitral annulus diastolic velocity. European Journal of Radiology
CrossRef96
U.C. Hoppe, E. Erdmann. (2010) Herzinsuffizienz Update 2010 und aktuelle ESC-Leitlinien. Herz 35:8, 535-541
CrossRef97
Na Li, Hongjun Bian, Juan Zhang, Xiaoxing Li, Xiaoping Ji, Yun Zhang. (2010) The Th17/Treg imbalance exists in patients with heart failure with normal ejection fraction and heart failure with reduced ejection fraction. Clinica Chimica Acta 411:23-24, 1963-1968
CrossRef98
B.-J. Kwon, D.-B. Kim, S.-W. Jang, K.-D. Yoo, K.-W. Moon, B. J. Shim, S.-H. Ahn, E.-J. Cho, T.-H. Rho, J.-H. Kim. (2010) Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease. European Journal of Heart Failure 12:12, 1339-1344
CrossRef99
Per Svensson, Helena Sundberg, Lars H. Lund, Jan Östergren. (2010) Change in blood pressure during hospitalisation for acute heart failure predicts mortality. Scandinavian Cardiovascular Journal 44:6, 325-330
CrossRef100
B. R. Lindman, M. M. Chakinala. (2010) Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension. International Journal of Clinical Practice 64, 15-22
CrossRef101
Adel Boueiz, Stephen C Mathai, Laura K Hummers, Paul M Hassoun. (2010) Cardiac complications of systemic sclerosis: recent progress in diagnosis. Current Opinion in Rheumatology 22:6, 696-703
CrossRef102
Micha T. Maeder, David M. Kaye. (2010) Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction
CrossRef103
Justin A. Ezekowitz, Michael A. McDonald. 2010. Management of Comorbidity in Chronic Heart Failure. , 137-156.
CrossRef104
Mark D. O'Neill, Matthew Wright, Pierre Jaïs, Sebastien Knecht, Isabelle Nault, Seiichiro Matsuo, Shinsuke Miyazaki, Andrej Pernat, Amir Jadidi, Frédéric Sacher, D. Wyn Davies, Jacques Clémenty, Michel Haïssaguerre, Mélèze Hocini. 2010. Treatment of Atrial Arrhythmias in Heart Failure Patients. , 217-234.
CrossRef105
Margaret M. Redfield. 2010. Recognising and Managing the Patient with Heart Failure and Preserved Ejection Fraction. , 255-286.
CrossRef106
Vivencio Barrios, Carlos Escobar, Alex De La Sierra, José Luis Llisterri, Diego González-Segura. (2010) Detection of unrecognized clinical heart failure in elderly hypertensive women attended in primary care setting. Blood Pressure 19:5, 301-307
CrossRef107
Zhiqiang Guan, Di Zhang, Rongjie Huang, Fang Zhang, Qingrong Wang, Shenglan Guo. (2010) Association of Left Atrial Myocardial Function With Left Ventricular Diastolic Dysfunction in Subjects With Preserved Systolic Function: A Strain Rate Imaging Study. Clinical Cardiology 33:10, 643-649
CrossRef108
M. Kasner, R. Gaub, D. Sinning, D. Westermann, P. Steendijk, W. Hoffmann, H.-P. Schultheiss, C. Tschope. (2010) Global strain rate imaging for the estimation of diastolic function in HFNEF compared with pressure-volume loop analysis. European Journal of Echocardiography 11:9, 743-751
CrossRef109
K. van den Hurk, M. Alssema, O. Kamp, R. M. Henry, C. D. Stehouwer, M. Diamant, F. Boomsma, R. J. Heine, G. Nijpels, W. J. Paulus, J. M. Dekker. (2010) Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study. European Journal of Heart Failure 12:9, 958-965
CrossRef110
Farouk Mookadam, Jamil Tajik. (2010) Back to the future: of fevers and failures. Future Cardiology 6:5, 567-569
CrossRef111
Saul Blecker, Kunihiro Matsushita, Ervin Fox, Stuart D. Russell, Edgar R. Miller, Herman Taylor, Frederick Brancati, Josef Coresh. (2010) Left ventricular dysfunction as a risk factor for cardiovascular and noncardiovascular hospitalizations in African Americans. American Heart Journal 160:3, 488-495
CrossRef112
Jan-Peter van Kuijk, Willem-Jan Flu, Tabita M. Valentijn, Michel Chonchol, Ruud J. Kuiper, Hence J.M. Verhagen, Jeroen J. Bax, Don Poldermans. (2010) Influence of Left Ventricular Dysfunction (Diastolic Versus Systolic) on Long-Term Prognosis in Patients With Versus Without Diabetes Mellitus Having Elective Peripheral Arterial Surgery. The American Journal of Cardiology 106:6, 860-864
CrossRef113
Hirotsugu Yamada, Allan L. Klein. (2010) Diastology 2010: clinical approach to diastolic heart failure. Journal of Echocardiography 8:3, 65-79
CrossRef114
Tansu Karaahmet, Kursat Tigen, Cihan Dundar, Selcuk Pala, Ahmet Guler, Alev Kilicgedik, Cihan Cevik, Kamran Mahmutyazicioglu, Iclal Isiklar, Yelda Basaran. (2010) The Effect of Cardiac Fibrosis on Left Ventricular Remodeling, Diastolic Function, and N-Terminal Pro-B-Type Natriuretic Peptide Levels in Patients with Nonischemic Dilated Cardiomyopathy. Echocardiography 27:8, 954-960
CrossRef115
Sally C Inglis, Robyn A Clark, Finlay A McAlister, Jocasta Ball, Christian Lewinter, Damien Cullington, Simon Stewart, John GF Cleland, Sally C Inglis. 2010. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. .
CrossRef116
Pavittarpaul Dhesi, Robert D Willix, Anita Phan, Faramarz Tehrani, Daniel Daneshvar, Ernst R Schwarz. (2010) Heart failure in the elderly: diastolic heart failure, medical therapy, women and end-of-life care. Aging Health 6:4, 429-437
CrossRef117
F. Edelmann, A. G. Schmidt, G. Gelbrich, L. Binder, C. Herrmann-Lingen, M. Halle, G. Hasenfuss, R. Wachter, B. Pieske. (2010) Rationale and design of the 'aldosterone receptor blockade in diastolic heart failure' trial: a double-blind, randomized, placebo-controlled, parallel group study to determine the effects of spironolactone on exercise capacity and diastolic function in patients with symptomatic diastolic heart failure (Aldo-DHF). European Journal of Heart Failure 12:8, 874-882
CrossRef118
Tujana Boldanova, Markus Noveanu, Tobias Breidthardt, Mihael Potocki, Tobias Reichlin, Anne Taegtmeyer, Michael Christ, Kirsten Laule, Claudia Stelzig, Christian Mueller. (2010) Impact of history of heart failure on diagnostic and prognostic value of BNP: Results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) Study. International Journal of Cardiology 142:3, 265-272
CrossRef119
Rachel S Crowder, Brian K Irons, Gary Meyerrose, Charles F Seifert. (2010) Factors Associated with Increased Hospital Utilization in Patients with Heart Failure and Preserved Ejection Fraction. Pharmacotherapy 30:7, 646-653
CrossRef120
Alexander G. Logan, T. Douglas Bradley. (2010) Sleep Apnea and Cardiovascular Disease. Current Hypertension Reports 12:3, 182-188
CrossRef121
Geoffrey de Couto, Maral Ouzounian, Peter P. Liu. (2010) Early detection of myocardial dysfunction and heart failure. Nature Reviews Cardiology 7:6, 334-344
CrossRef122
Bodh I Jugdutt. (2010) Heart failure in the elderly: advances and challenges. Expert Review of Cardiovascular Therapy 8:5, 695-715
CrossRef123
Thomas E. Vanhecke, Robert Kim, Shaheena Z. Raheem, Peter A. McCullough. (2010) Myocardial Ischemia in Patients with Diastolic Dysfunction and Heart Failure. Current Cardiology Reports 12:3, 216-222
CrossRef124
Rebecca Scully, Steven E. Lipshultz. 2010. Cardiovascular Toxicity of Antitumor Drugs: Dimensions of the Problem in Children. , 97-126.
CrossRef125
Christophe Tribouilloy, Otilia Buiciuc, Dan Rusinaru, Dorothée Malaquin, Franck Lévy, Marcel Peltier. (2010) Long-term outcome after a first episode of heart failure. A prospective 7-year study. International Journal of Cardiology 140:3, 309-314
CrossRef126
Massimo Volpe, Robert McKelvie, Helmut Drexler. (2010) Hypertension as an Underlying Factor in Heart Failure With Preserved Ejection Fraction. The Journal of Clinical Hypertension 12:4, 277-283
CrossRef127
Xing-Guo Sun, James E. Hansen, John F. Beshai, Karlman Wasserman. (2010) Oscillatory Breathing and Exercise Gas Exchange Abnormalities Prognosticate Early Mortality and Morbidity in Heart Failure. Journal of the American College of Cardiology 55:17, 1814-1823
CrossRef128
Darryl P. Leong, Carmine G. De Pasquale, Joseph B. Selvanayagam. (2010) Heart Failure With Normal Ejection Fraction: The Complementary Roles of Echocardiography and CMR Imaging. JACC: Cardiovascular Imaging 3:4, 409-420
CrossRef129
Ioana Mozos, M. Hancu, N. Jost, A. Cristescu. (2010) Multipolar QRST isointegral maps and QT dispersion in old myocardial infarction. Acta Physiologica Hungarica 97:1, 11-21
CrossRef130
Giuseppe Limongelli, Giuseppe Pacileo, Roberta Ancona, Giuseppina Eusebio, Antonello D'Andrea, Massimo Romano, Giovanni Di Salvo, Alessandra Rea, Paolo Calabró, Giampaolo Romano, Ciro Maiello, Raffaele Calabró. (2010) Clinical Course and Risk Profile in Adolescents With Idiopathic Dilated Cardiomyopathy. The American Journal of Cardiology 105:5, 716-720
CrossRef131
Sadik Acikel, Ramazan Akdemir, Harun Kilic, Asuman Bicer Yesilay, Mehmet Dogan, Goksel Cagirci. (2010) Diastolic heart failure in elderly: The prognostic factors and interventions regarding heart failure with preserved ejection fraction. International Journal of Cardiology 138:3, 311-313
CrossRef132
Charles R Salters, Alison L Bailey, Thomas F Whayne. (2010) Current treatment of heart failure in the USA. Expert Review of Cardiovascular Therapy 8:2, 279-290
CrossRef133
Thanh T. Phan, Khalid Abozguia, Ganesh Nallur Shivu, Ibrar Ahmed, Kiran Patel, Francisco Leyva, Michael Frenneaux. (2010) Myocardial Contractile Inefficiency and Dyssynchrony in Heart Failure With Preserved Ejection Fraction and Narrow QRS Complex. Journal of the American Society of Echocardiography 23:2, 201-206
CrossRef134
M. T. Vidan, H. Bueno, Y. Wang, G. Schreiner, J. S. Ross, J. Chen, H. M. Krumholz. (2010) The relationship between systolic blood pressure on admission and mortality in older patients with heart failure. European Journal of Heart Failure 12:2, 148-155
CrossRef135
Don Poldermans, Jeroen J Bax, Eric Boersma, Stefan De Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, Jose Lopez-Sendon, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav FM Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2010) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. European Journal of Anaesthesiology 27:2, 92-137
CrossRef136
J. Zhou, H. Shi, J. Zhang, Y. Lu, M. Fu, J. Ge, . (2010) Rationale and design of the -blocker in heart failure with normal left ventricular ejection fraction ( -PRESERVE) study. European Journal of Heart Failure 12:2, 181-185
CrossRef137
Andrea Bellone, Massimiliano Etteri, Marco Vettorello, Vittorio Berruti, Carlo Maino, Massimo Mariani, Dante Clerici, Italo Nessi, Giancarlo Gini, Anna Natalizi, Pietro Brunati. (2010) The effects of continuous positive airway pressure on plasma brain natriuretic peptide concentrations in patients presenting with acute cardiogenic pulmonary edema with preserved left ventricular systolic function. The American Journal of Emergency Medicine 28:2, 230-234
CrossRef138
Yutaka Miura, Yoshihiro Fukumoto, Nobuyuki Shiba, Toshiro Miura, Kazunori Shimada, Yoshitaka Iwama, Atsutoshi Takagi, Hidenori Matsusaka, Takaki Tsutsumi, Akira Yamada, Shintaro Kinugawa, Masanori Asakura, Shuichi Okamatsu, Hiroyuki Tsutsui, Hiroyuki Daida, Masunori Matsuzaki, Hitonobu Tomoike, Hiroaki Shimokawa. (2010) Prevalence and Clinical Implication of Metabolic Syndrome in Chronic Heart Failure. Circulation Journal 74:12, 2612-2621
CrossRef139
David H MacIver. (2010) Current controversies in heart failure with a preserved ejection fraction. Future Cardiology 6:1, 97-111
CrossRef140
John P. Konhilas. (2010) What We Know and Do Not Know about Sex and Cardiac Disease. Journal of Biomedicine and Biotechnology 2010, 1-12
CrossRef141
David A. Kass, Dalane W. Kitzman, Guy E. Alvarez. (2010) The Restoration of Chronotropic CompEtence in Heart Failure PatientS with Normal Ejection FracTion (RESET) Study: Rationale and Design. Journal of Cardiac Failure 16:1, 17-24
CrossRef142
A. Jonsson, M. Edner, U. Alehagen, U. Dahlstrom. (2010) Heart failure registry: a valuable tool for improving the management of patients with heart failure. European Journal of Heart Failure 12:1, 25-31
CrossRef143
Sanjiv J. Shah. (2010) Evolving Approaches to the Management of Heart Failure with Preserved Ejection Fraction in Patients with Coronary Artery Disease. Current Treatment Options in Cardiovascular Medicine 12:1, 58-75
CrossRef144
Jens Seiler, William G. Stevenson. (2010) Atrial Fibrillation in Congestive Heart Failure. Cardiology in Review 18:1, 38-50
CrossRef145
R. Wachter, S. Schmidt-Schweda, D. Westermann, H. Post, F. Edelmann, M. Kasner, C. Luers, P. Steendijk, G. Hasenfuss, C. Tschope, B. Pieske. (2009) Blunted frequency-dependent upregulation of cardiac output is related to impaired relaxation in diastolic heart failure. European Heart Journal 30:24, 3027-3036
CrossRef146
Thanh T. Phan, Khalid Abozguia, Ganesh Nallur Shivu, Ibrar Ahmed, Francisco Leyva, Kiran Patel, Michael Frenneaux. (2009) Increased Atrial Contribution to Left Ventricular Filling Compensates for Impaired Early Filling During Exercise in Heart Failure With Preserved Ejection Fraction. Journal of Cardiac Failure 15:10, 890-897
CrossRef147
R. Füth, W. Dinh, L. Bansemir, G. Ziegler, A. Bufe, J. Wolfertz, T. Scheffold, Mark Lankisch. (2009) Newly detected glucose disturbance is associated with a high prevalence of diastolic dysfunction: double risk for the development of heart failure?. Acta Diabetologica 46:4, 335-338
CrossRef148
Don Poldermans, Jeroen J. Bax, Eric Boersma, Stefan de Hert, Erik Eeckhout, Gerry Fowkes, Bulent Gorenek, Michael G. Hennerici, Bernard Iung, Malte Kelm, Keld Per Kjeldsen, Steen Dalby Kristensen, José López-Sendón, Paolo Pelosi, François Philippe, Luc Pierard, Piotr Ponikowski, Jean-Paul Schmid, Olav F.M. Sellevold, Rosa Sicari, Greet Van den Berghe, Frank Vermassen. (2009) Guía de práctica clínica para la valoración del riesgo cardiaco preoperatorio y el manejo cardiaco perioperatorio en la cirugía no cardiaca. Revista Española de Cardiología 62:12, 1467.e1-1467.e56
CrossRef149
Alan Maisel. (2009) Natriuretic Peptide-Guided Therapy for Heart Failure. Journal of the American College of Cardiology 55:1, 61-64
CrossRef150
Larry A. Allen, Kevin J. Anstrom, John R. Horton, Linda K. Shaw, Eric L. Eisenstein, G. Michael Felker. (2009) Relationship Between Anemia and Health Care Costs in Heart Failure. Journal of Cardiac Failure 15:10, 843-849
CrossRef151
, D. Poldermans, J. J. Bax, E. Boersma, S. De Hert, E. Eeckhout, G. Fowkes, B. Gorenek, M. G. Hennerici, B. Iung, M. Kelm, K. P. Kjeldsen, S. D. Kristensen, J. Lopez-Sendon, P. Pelosi, F. Philippe, L. Pierard, P. Ponikowski, J.-P. Schmid, O. F.M. Sellevold, R. Sicari, G. Van den Berghe, F. Vermassen, , S. E. Hoeks, I. Vanhorebeek, , A. Vahanian, A. Auricchio, J. J. Bax, C. Ceconi, V. Dean, G. Filippatos, C. Funck-Brentano, R. Hobbs, P. Kearney, T. McDonagh, K. McGregor, B. A. Popescu, Z. Reiner, U. Sechtem, P. A. Sirnes, M. Tendera, P. Vardas, P. Widimsky, , R. De Caterina, S. Agewall, N. Al Attar, F. Andreotti, S. D. Anker, G. Baron-Esquivias, G. Berkenboom, L. Chapoutot, R. Cifkova, P. Faggiano, S. Gibbs, H. S. Hansen, L. Iserin, C. W. Israel, R. Kornowski, N. M. Eizagaechevarria, M. Pepi, M. Piepoli, H. J. Priebe, M. Scherer, J. Stepinska, D. Taggart, M. Tubaro. (2009) Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: The Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). European Heart Journal 30:22, 2769-2812
CrossRef152
Ibrahim Almuntaser, Azra Mahmud, Angie Brown, Ross Murphy, Gerard King, Peter Crean, John Feely. (2009) Blood Pressure Control Determines Improvement in Diastolic Dysfunction in Early Hypertension. American Journal of Hypertension 22:11, 1227-1231
CrossRef153
S. Arques, B. Pieri, G. Biegle, E. Roux, R. Gelisse, B. Jauffret. (2009) Valeur prédictive comparée de mortalité hospitalière du peptide natriurétique de type B et de l’albuminémie chez le sujet âgé hospitalisé pour insuffisance cardiaque aiguë sévère. Annales de Cardiologie et d'Angéiologie 58:5, 279-283
CrossRef154
M. Khaled Shamseddin, Patrick S. Parfrey. (2009) Mechanisms of the cardiorenal syndromes. Nature Reviews Nephrology 5:11, 641-649
CrossRef155
Hoong Sern Lim, Roger Beadle, Michael Frenneaux. (2009) Death and Dying in Heart Failure With Normal Ejection Fraction. The American Journal of Cardiology 104:9, 1311-1314
CrossRef156
F. Zannad, N. Agrinier, F. Alla. (2009) Heart failure burden and therapy. Europace 11:Supplement 5, v1-v9
CrossRef157
Claudio Ronco, Dinna N Cruz, Federico Ronco. (2009) Cardiorenal syndromes. Current Opinion in Critical Care 15:5, 384-391
CrossRef158
Andrea Bellone, Marco Vettorello, Massimiliano Etteri, Chiara Bonetti, Giancarlo Gini, Massimo Mariani, Vittorio Berruti, Dante Clerici, Chiara Minelli, Italo Nessi, Carlo Maino. (2009) The role of continuous positive airway pressure in acute cardiogenic edema with preserved left ventricular systolic function. The American Journal of Emergency Medicine 27:8, 986-991
CrossRef159
Sachin S Soni, Yuan Fahuan, Claudio Ronco, Dinna N Cruz. (2009) Cardiorenal syndrome: biomarkers linking kidney damage with heart failure. Biomarkers in Medicine 3:5, 549-560
CrossRef160
Manuel Méndez Bailón, Nuria Muñoz Rivas, Javier Ortiz Alonso, Luis Audibert Mena. (2009) Pronóstico global en la insuficiencia cardíaca: hipertensión pulmonar y comorbilidad. Medicina Clínica 133:14, 565-566
CrossRef161
Soko Setoguchi, Lynne Warner Stevenson. (2009) Hospitalizations in Patients With Heart Failure: Who and Why
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.. Journal of the American College of Cardiology 54:18, 1703-1705
CrossRef162
M. Montero Pérez-Barquero. (2009) Insuficiencia cardíaca con función sistólica preservada: pronóstico. Revista Clínica Española 209, 30-35
CrossRef163
Mathew S. Maurer. (2009) Heart Failure With a Normal Ejection Fraction (HFNEF): Embracing Complexity. Journal of Cardiac Failure 15:7, 561-564
CrossRef164
Andreas Kalogeropoulos, Vasiliki Georgiopoulou, Tamara B. Harris, Stephen B. Kritchevsky, Douglas C. Bauer, Andrew L. Smith, Elsa Strotmeyer, Anne B. Newman, Peter W.F. Wilson, Bruce M. Psaty, Javed Butler. (2009) Glycemic Status and Incident Heart Failure in Elderly Without History of Diabetes Mellitus: The Health, Aging, and Body Composition Study. Journal of Cardiac Failure 15:7, 593-599
CrossRef165
E. Visús, E. Gargallo, P. Conthe. (2009) Novedades terapéuticas: estudio I-PRESERVE. Revista Clínica Española 209, 36-40
CrossRef166
J. Montes-Santiago. (2009) Insuficiencia cardíaca con función sistólica conservada. Definición y epidemiología. Revista Clínica Española 209, 3-10
CrossRef167
Samer S. Najjar. (2009) Evolving insights into the pathophysiology of heart failure with preserved ejection fraction. Current Cardiovascular Risk Reports 3:5, 374-379
CrossRef168
Scott L. Hummel, Stephen Skorcz, Todd M. Koelling. (2009) Prolonged Electrocardiogram QRS Duration Independently Predicts Long-Term Mortality in Patients Hospitalized for Heart Failure With Preserved Systolic Function. Journal of Cardiac Failure 15:7, 553-560
CrossRef169
Daniel Forman, J. Michael Gaziano. (2009) Irbesartan in patients with heart failure and preserved ejection fraction. Current Cardiovascular Risk Reports 3:5, 311-312
CrossRef170
Yukio Mizuguchi, Yoshifumi Oishi, Hirokazu Miyoshi, Arata Iuchi, Norio Nagase, Takashi Oki. (2009) Beneficial effects of telmisartan on left ventricular structure and function in patients with hypertension determined by two-dimensional strain imaging. Journal of Hypertension 27:9, 1892-1899
CrossRef171
J. B. Somaratne, C. Berry, J. J.V. McMurray, K. K. Poppe, R. N. Doughty, G. A. Whalley. (2009) The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis. European Journal of Heart Failure 11:9, 855-862
CrossRef172
M. Quintana, R. Centurión, J.M. Cepeda. (2009) Evaluación diagnóstica. Revista Clínica Española 209, 15-22
CrossRef173
T. T. Phan, G. N. Shivu, K. Abozguia, M. Gnanadevan, I. Ahmed, M. Frenneaux. (2009) Left ventricular torsion and strain patterns in heart failure with normal ejection fraction are similar to age-related changes. European Journal of Echocardiography 10:6, 793-800
CrossRef174
Kazuaki Uchino, Tomoaki Ishigami, Kenji Ohshige, Teruyasu Sugano, Toshiyuki Ishikawa, Kazuo Kimura, Satohshi Umemura. (2009) Left ventricular geometry, risk factors, and outcomes of hospitalized patients with diastolic heart failure in Japan. Journal of Cardiology 54:1, 101-107
CrossRef175
S. Puwanant, T. C. Priester, F. Mookadam, C. J. Bruce, M. M. Redfield, K. Chandrasekaran. (2009) Right ventricular function in patients with preserved and reduced ejection fraction heart failure. European Journal of Echocardiography 10:6, 733-737
CrossRef176
Goo-Yeong Cho, Thomas H. Marwick, Hyun-Sook Kim, Min-Kyu Kim, Kyung-Soon Hong, Dong-Jin Oh. (2009) Global 2-Dimensional Strain as a New Prognosticator in Patients With Heart Failure. Journal of the American College of Cardiology 54:7, 618-624
CrossRef177
Rajesh Janardhanan, Akshay S. Desai, Scott D. Solomon. (2009) Therapeutic approaches to diastolic dysfunction. Current Hypertension Reports 11:4, 283-291
CrossRef178
Oliver J. Rider, Jane M. Francis, Mohammed K. Ali, Steffen E. Petersen, Monique Robinson, Matthew D. Robson, James P. Byrne, Kieran Clarke, Stefan Neubauer. (2009) Beneficial Cardiovascular Effects of Bariatric Surgical and Dietary Weight Loss in Obesity. Journal of the American College of Cardiology 54:8, 718-726
CrossRef179
Eileen M. Hsich, Ileana L. Piña. (2009) Heart Failure in Women. Journal of the American College of Cardiology 54:6, 491-498
CrossRef180
Wei Zhang, Sándor J. Kovács. (2009) The Age Dependence of Left Ventricular Filling Efficiency. Ultrasound in Medicine & Biology 35:7, 1076-1085
CrossRef181
Thanh T. Phan, Khalid Abozguia, Ganesh Nallur Shivu, Gnanadevan Mahadevan, Ibrar Ahmed, Lynne Williams, Girish Dwivedi, Kiran Patel, Paul Steendijk, Houman Ashrafian, Anke Henning, Michael Frenneaux. (2009) Heart Failure With Preserved Ejection Fraction Is Characterized by Dynamic Impairment of Active Relaxation and Contraction of the Left Ventricle on Exercise and Associated With Myocardial Energy Deficiency. Journal of the American College of Cardiology 54:5, 402-409
CrossRef182
Samer S. Najjar. (2009) Heart Failure With Preserved Ejection Fraction. Journal of the American College of Cardiology 54:5, 419-421
CrossRef183
Fernando Otero-Raviña, Lilian Grigorian-Shamagian, Luis Fransi-Galiana, Carlos Názara-Otero, José Ma Fernández-Villaverde, Alberto del Álamo-Alonso, Enrique Nieto-Pol, Miguel de Santiago-Boullón, Isidro López-Rodríguez, José Ma Cardona-Vidal, Alfonso Varela-Román, José R. González-Juanatey. (2009) Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP study. International Journal of Cardiology 136:1, 56-63
CrossRef184
Alan B. Miller, Ileana L. Piña. (2009) Understanding Heart Failure With Preserved Ejection Fraction: Clinical Importance and Future Outlook. Congestive Heart Failure 15:4, 186-192
CrossRef185
T. Bitter, L. Faber, D. Hering, C. Langer, D. Horstkotte, O. Oldenburg. (2009) Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. European Journal of Heart Failure 11:6, 602-608
CrossRef186
Yu Ting Tan, Frauke Wenzelburger, Eveline Lee, Grant Heatlie, Francisco Leyva, Kiran Patel, Michael Frenneaux, John E. Sanderson. (2009) The Pathophysiology of Heart Failure With Normal Ejection Fraction. Journal of the American College of Cardiology 54:1, 36-46
CrossRef187
Dirk J. van Veldhuisen, Alain Cohen-Solal, Michael Böhm, Stefan D. Anker, Daphne Babalis, Michael Roughton, Andrew J.S. Coats, Philip A. Poole-Wilson, Marcus D. Flather. (2009) Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction. Journal of the American College of Cardiology 53:23, 2150-2158
CrossRef188
Shigefumi Fukui, Yoshihiro Fukumoto, Jun Suzuki, Kenya Saji, Jun Nawata, Tsuyoshi Shinozaki, Yutaka Kagaya, Jun Watanabe, Hiroaki Shimokawa. (2009) Diabetes mellitus accelerates left ventricular diastolic dysfunction through activation of the renin–angiotensin system in hypertensive rats. Hypertension Research 32:6, 472-480
CrossRef189
Kaivan Khavandi, Ali Khavandi, Omar Asghar, Adam Greenstein, Sarah Withers, Anthony M. Heagerty, Rayaz A. Malik. (2009) Diabetic cardiomyopathy – a distinct disease?. Best Practice & Research Clinical Endocrinology & Metabolism 23:3, 347-360
CrossRef190
Vinay Thohan, Shomeet Patel. (2009) The challenges associated with current clinical trials for diastolic heart failure. Current Opinion in Cardiology 24:3, 230-238
CrossRef191
Anil Verma, Scott D. Solomon. (2009) Diastolic Dysfunction as a Link Between Hypertension and Heart Failure. Medical Clinics of North America 93:3, 647-664
CrossRef192
Benjamin H. Freed, Roberto M. Lang. (2009) The use of echocardiography in predicting heart failure in patients with coronary artery disease. Current Cardiology Reports 11:3, 155-156
CrossRef193
Ana Maestre, Vicente Gil, Javier Gallego, Miguel García, Fernando García de Burgos, Alberto Martín-Hidalgo. (2009) Prediction clinical profile to distinguish between systolic and diastolic heart failure in hospitalized patients. European Journal of Internal Medicine 20:3, 313-318
CrossRef194
G W Yip, J W H Fung, Y-T Tan, J E Sanderson. (2009) Hypertension and heart failure: a dysfunction of systole, diastole or both?. Journal of Human Hypertension 23:5, 295-306
CrossRef195
Mariell Jessup, William T. Abraham, Donald E. Casey, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Marvin A. Konstam, Donna M. Mancini, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, 1343-1382
CrossRef196
Sharon Ann Hunt, William T. Abraham, Marshall H. Chin, Arthur M. Feldman, Gary S. Francis, Theodore G. Ganiats, Mariell Jessup, Marvin A. Konstam, Donna M. Mancini, Keith Michl, John A. Oates, Peter S. Rahko, Marc A. Silver, Lynne Warner Stevenson, Clyde W. Yancy. (2009) 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. Journal of the American College of Cardiology 53:15, e1-e90
CrossRef197
Oleg Gorelik, Dorit Almoznino-Sarafian, Miriam Shteinshnaider, Irena Alon, Irma Tzur, Ilya Sokolsky, Shai Efrati, Zoanna Babakin, David Modai, Natan Cohen. (2009) Clinical variables affecting survival in patients with decompensated diastolic versus systolic heart failure. Clinical Research in Cardiology 98:4, 224-232
CrossRef198
Maral Ouzounian, Jack V. Tu, Peter C. Austin, Alice Chong, Peter P. Liu, Douglas S. Lee. (2009) Statin Therapy and Clinical Outcomes in Heart Failure: A Propensity-Matched Analysis. Journal of Cardiac Failure 15:3, 241-248
CrossRef199
Saraswathy Manickavasagam, Ramanna Merla, Michael M Koerner, Ken Fujise, Sanjay Kunapuli, Salvatore Rosanio, Alejandro Barbagelata. (2009) Management of hypertension in chronic heart failure. Expert Review of Cardiovascular Therapy 7:4, 423-433
CrossRef200
(2009) Irbesartan for Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine 360:12, 1256-1259
Full Text201
Micha T. Maeder, David M. Kaye. (2009) Heart Failure With Normal Left Ventricular Ejection Fraction. Journal of the American College of Cardiology 53:11, 905-918
CrossRef202
Alexander N. Borg, Simon G. Ray. (2009) A Unifying Framework for Understanding Heart Failure? Response to “Left Ventricular Torsion by Two-Dimensional Speckle Tracking Echocardiography in Patients With Diastolic Dysfunction and Normal Ejection Fraction” by Park SJ et al.. Journal of the American Society of Echocardiography 22:3, 318-320
CrossRef203
Timothy P. Fitzgibbons, Theo E. Meyer, Gerard P. Aurigemma. (2009) Mortality in Diastolic Heart Failure. Cardiology in Review 17:2, 51-55
CrossRef204
Carsten Tschöpe, Dirk Westermann. (2009) Heart Failure with Normal Ejection Fraction. Herz Kardiovaskuläre Erkrankungen 34:2, 89-96
CrossRef205
Karl E. Hammermeister, Diane Fairclough, Caroline Bublitz Emsermann, Richard Hamman, Michael Ho, Stephanie Phibbs, Mary Plomondon, Robert Valuck, David West, John F. Steiner. (2009) Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure. Clinical Therapeutics 31:3, 632-643
CrossRef206
Niraj Parekh, Alan S Maisel. (2009) Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. Current Opinion in Cardiology 24:2, 155-160
CrossRef207
Vincent L. Sorrell, Nishant Kalra, Radhakrishnan Ramaraj. (2009) Impact of Diastolic Dysfunction on Heart Failure-Related Hospitalizations. Journal of the American College of Cardiology 53:5, 457
CrossRef208
E. Donal, L. H. Lund, C. Linde, M. Edner, S. Lafitte, H. Persson, F. Bauer, J. Ohrvik, P.-V. Ennezat, C. Hage, I. Lofman, Y. Juilliere, D. Logeart, G. Derumeaux, P. Gueret, J.-C. Daubert. (2009) Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction. European Journal of Heart Failure 11:2, 198-204
CrossRef209
Barry A. Borlaug. (2009) Treatment of heart failure with preserved ejection fraction. Current Treatment Options in Cardiovascular Medicine 11:1, 79-87
CrossRef210
Dan Rusinaru, Otilia Buiciuc, Laurent Leborgne, Michel Slama, Ziad Massy, Christophe Tribouilloy. (2009) Relation of Serum Sodium Level to Long-Term Outcome After a First Hospitalization for Heart Failure With Preserved Ejection Fraction. The American Journal of Cardiology 103:3, 405-410
CrossRef211
N. M. Hawkins, M. C. Petrie, P. S. Jhund, G. W. Chalmers, F. G. Dunn, J. J.V. McMurray. (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. European Journal of Heart Failure 11:2, 130-139
CrossRef212
O. Dar, J. Riley, C. Chapman, S. W. Dubrey, S. Morris, S. D. Rosen, M. Roughton, M. R. Cowie. (2009) A randomized trial of home telemonitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. European Journal of Heart Failure 11:3, 319-325
CrossRef213
Kazuhiro Yamamoto, Yasushi Sakata, Tomohito Ohtani, Yasuharu Takeda, Toshiaki Mano. (2009) Heart Failure With Preserved Ejection Fraction. Circulation Journal 73:3, 404-410
CrossRef214
Akiyoshi Hashimoto, Tomoaki Nakata, Takeru Wakabayashi, Hideo Kusuoka, Tsunehiko Nishimura. (2009) Incremental Prognostic Value of Stress/Rest Gated Perfusion SPECT in Patients With Coronary Artery Disease. Circulation Journal 73:12, 2288-2293
CrossRef215
Sudhansu Chokroverty. 2009. Sleep Disturbances in General Medical Disorders. , 550-580.
CrossRef216
Jon W. Schrock, Charles L. Emerman. (2009) Observation Unit Management of Acute Decompensated Heart Failure. Heart Failure Clinics 5:1, 85-100
CrossRef217
James D. Flaherty, Jeroen J. Bax, Leonardo De Luca, Joseph S. Rossi, Charles J. Davidson, Gerasimos Filippatos, Peter P. Liu, Marvin A. Konstam, Barry Greenberg, Mandeep R. Mehra, Günter Breithardt, Peter S. Pang, James B. Young, Gregg C. Fonarow, Robert O. Bonow, Mihai Gheorghiade. (2009) Acute Heart Failure Syndromes in Patients With Coronary Artery Disease. Journal of the American College of Cardiology 53:3, 254-263
CrossRef218
Sean P. Collins, Alan B. Storrow. (2009) Acute Heart Failure Risk Stratification: Can We Define Low Risk?. Heart Failure Clinics 5:1, 75-83
CrossRef219
Kenji Miyagishima, Shinya Hiramitsu, Hisashi Kimura, Kazumasa Mori, Tomoya Ueda, Shigeru Kato, Yasuchika Kato, Shiho Ishikawa, Masatsugu Iwase, Shin-ichiro Morimoto, Hitoshi Hishida, Yukio Ozaki. (2009) Long Term Prognosis of Chronic Heart Failure. Circulation Journal 73:1, 92-99
CrossRef220
Joseph F. Styron, Preeti Jois-Bilowich, Randall Starling, Robert E. Hobbs, Michael C. Kontos, Peter S. Pang, W. Frank Peacock. (2009) Initial Emergency Department Systolic Blood Pressure Predicts Left Ventricular Systolic Function in Acute Decompensated Heart Failure. Congestive Heart Failure 15:1, 9-13
CrossRef221
Robert S McKelvie. (2009) The CHARM program: the effects of candesartan for the management of patients with chronic heart failure. Expert Review of Cardiovascular Therapy 7:1, 9-16
CrossRef222
Krishna K. Gaddam, Suzanne Oparil. (2009) Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy. Journal of the American Society of Hypertension 3:1, 52-68
CrossRef223
Miguel A. Quinones. (2009) Role of Echocardiography in Predicting Onset of Heart Failure in Patients With Stable Coronary Artery Disease. JACC: Cardiovascular Imaging 2:1, 21-23
CrossRef224
Marek Roik. (2009) Statin Therapy in Patients With Heart Failure and Preserved Left Ventricular Function. Circulation Journal 73:7, 1359
CrossRef225
Massie, Barry M., Carson, Peter E., McMurray, John J., Komajda, Michel, McKelvie, Robert, Zile, Michael R., Anderson, Susan, Donovan, Mark, Iverson, Erik, Staiger, Christoph, Ptaszynska, Agata, . (2008) Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction. New England Journal of Medicine 359:23, 2456-2467
Full Text226
Biju Paul, Kean H. Soon, James Dunne, Carmine G. De Pasquale. (2008) Diagnostic and Prognostic Significance of Plasma N-Terminal-Pro-Brain Natriuretic Peptide in Decompensated Heart Failure with Preserved Ejection Fraction. Heart, Lung and Circulation 17:6, 497-501
CrossRef227
(2008) Guía de práctica clínica de la Sociedad Europea de Cardiología (ESC) para el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica (2008). Revista Española de Cardiología 61:12, 1329.e1-1329.e70
CrossRef228
Heidi N. Schmaltz, Danielle A. Southern, Colleen J. Maxwell, Merril L. Knudtson, William A. Ghali, . (2008) Patient Sex Does Not Modify Ejection Fraction as a Predictor of Death in Heart Failure: Insights from the APPROACH Cohort. Journal of General Internal Medicine 23:12, 1940-1946
CrossRef229
Anita Deswal, Biykem Bozkurt. (2008) Treatment of patients with heart failure and preserved ejection fraction. Current Treatment Options in Cardiovascular Medicine 10:6, 516-528
CrossRef230
Lilian Grigorian-Shamagian, Fernando Otero Raviña, Emad Abu Assi, Rafael Vidal Perez, Elvis Teijeira-Fernandez, Alfonso Varela Roman, Laura Moreira Sayagues, Jose Ramon Gonzalez-Juanatey. (2008) Why and when do patients with heart failure and normal left ventricular ejection fraction die? Analysis of >600 deaths in a community long-term study. American Heart Journal 156:6, 1184-1190
CrossRef231
Michael Kindermann, Jan-Christian Reil, Burkert Pieske, Dirk J. van Veldhuisen, Michael Böhm. (2008) Heart Failure With Normal Left Ventricular Ejection Fraction: What is the Evidence?. Trends in Cardiovascular Medicine 18:8, 280-292
CrossRef232
Claudio Ronco, Mikko Haapio, Andrew A. House, Nagesh Anavekar, Rinaldo Bellomo. (2008) Cardiorenal Syndrome. Journal of the American College of Cardiology 52:19, 1527-1539
CrossRef233
Carlo Rostagno, Gabriele Rosso, Francesco Puggelli, Gian Franco Gensini. (2008) Preserved systolic ventricular function heart failure patients referred to a division of internal medicine. European Journal of Internal Medicine 19:7, 511-515
CrossRef234
Abhijit A. Shinde, Allen S. Anderson. (2008) Treatment of Hypertension in Heart Failure with Preserved Ejection Fraction: Role of the Kidney. Heart Failure Clinics 4:4, 479-503
CrossRef235
, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, A. Keren, A. Mebazaa, M. Nieminen, S. G. Priori, K. Swedberg, , A. Vahanian, J. Camm, R. De Caterina, V. Dean, K. Dickstein, G. Filippatos, C. Funck-Brentano, I. Hellemans, S. D. Kristensen, K. McGregor, U. Sechtem, S. Silber, M. Tendera, P. Widimsky, J. L. Zamorano, , M. Tendera, A. Auricchio, J. Bax, M. Bohm, U. Corra, P. della Bella, P. M. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J.-L. Vachiery, F. W. A. Verheugt, J. L. Zamorano, F. Zannad. (2008) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). European Heart Journal 29:19, 2388-2442
CrossRef236
Brenda Thompson, Mark H. Drazner, Daniel L. Dries, Clyde W. Yancy. (2008) Systolic Time Ratio by Impedance Cardiography to Distinguish Preserved vs Impaired Left Ventricular Systolic Function in Heart Failure. Congestive Heart Failure 14:5, 261-265
CrossRef237
B. A. Brooks, B. Franjic, C. R. Ban, K. Swaraj, D. K. Yue, D. S. Celermajer, S. M. Twigg. (2008) Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes. Diabetes, Obesity and Metabolism 10:9, 739-746
CrossRef238
Jasper W.L. Hartog, Yoran M. Hummel, Adriaan A. Voors, Casper G. Schalkwijk, Toshio Miyata, Roel M. Huisman, Andries J. Smit, Dirk J. Van Veldhuisen. (2008) Skin-Autofluorescence, a Measure of Tissue Advanced Glycation End-Products (AGEs), is Related to Diastolic Function in Dialysis Patients. Journal of Cardiac Failure 14:7, 596-602
CrossRef239
William H. Gaasch, Dennis E. Delorey, Martin G. St. John Sutton, Michael R. Zile. (2008) Patterns of Structural and Functional Remodeling of the Left Ventricle in Chronic Heart Failure. The American Journal of Cardiology 102:4, 459-462
CrossRef240
Anne K. Chung, Peter S. Pang, Gregg C. Fonarow, Mihai Gheorghiade. (2008) Acute heart failure syndromes: Potential strategies to improve post-discharge outcomes. Current Treatment Options in Cardiovascular Medicine 10:4, 349-357
CrossRef241
Christian Werner, Milad Hanhoun, Thomas Widmann, Andrey Kazakov, Alexander Semenov, Janine Pöss, Johann Bauersachs, Thomas Thum, Michael Pfreundschuh, Patrick Müller, Judith Haendeler, Michael Böhm, Ulrich Laufs. (2008) Effects of Physical Exercise on Myocardial Telomere-Regulating Proteins, Survival Pathways, and Apoptosis. Journal of the American College of Cardiology 52:6, 470-482
CrossRef242
Burkert Pieske, Rolf Wachter. (2008) Impact of diabetes and hypertension on the heart. Current Opinion in Cardiology 23:4, 340-349
CrossRef243
Maral Ouzounian, Douglas S Lee, Peter P Liu. (2008) Diastolic heart failure: mechanisms and controversies. Nature Clinical Practice Cardiovascular Medicine 5:7, 375-386
CrossRef244
Julio Núñez, Luis Mainar, Vicent Bodí, Juan Sanchis, Eduardo Núñez, Gema Miñana, Oliver Husser, María José Bosch, Francisco J. Chorro, Àngel Llàcer. (2008) Valor pronóstico de la fracción de eyección del ventrículo izquierdo en pacientes con insuficiencia cardíaca aguda. Medicina Clínica 131:5, 161-166
CrossRef245
Justin A. Ezekowitz, Douglas S. Lee, Jack V. Tu, Alice M. Newman, Finlay A. McAlister. (2008) Comparison of One-Year Outcome (Death and Rehospitalization) in Hospitalized Heart Failure Patients With Left Ventricular Ejection Fraction >50% Versus Those With Ejection Fraction <50%. The American Journal of Cardiology 102:1, 79-83
CrossRef246
Serge Lepage. (2008) Acute decompensated heart failure. Canadian Journal of Cardiology 24, 6B-8B
CrossRef247
Girish Dwivedi, Gregory YH Lip. (2008) The left atrium and diastolic dysfunction in hypertensive left ventricular hypertrophy: a consideration of size and function?. Journal of Hypertension 26:7, 1310-1312
CrossRef248
Peter P. Liu. (2008) Cardiorenal syndrome in heart failure: A cardiologist's perspective. Canadian Journal of Cardiology 24, 25B-29B
CrossRef249
Sanjiv J. Shah, Kenta Nakamura, Gregory M. Marcus, Ivor L. Gerber, Barry H. McKeown, Mark V. Jordan, Michele Huddleston, Elyse Foster, Andrew D. Michaels. (2008) Association of the Fourth Heart Sound With Increased Left Ventricular End-Diastolic Stiffness. Journal of Cardiac Failure 14:5, 431-436
CrossRef250
E. Donal. (2008) L’insuffisance cardiaque à fraction d’éjection préservée. La Revue de Médecine Interne 29, S6-S7
CrossRef251
M. Guazzi, J. Myers, M. A. Peberdy, D. Bensimhon, P. Chase, R. Arena. (2008) Exercise oscillatory breathing in diastolic heart failure: prevalence and prognostic insights. European Heart Journal 29:22, 2751-2759
CrossRef252
Aparajita Das, Selwin Abraham, Anita Deswal. (2008) Advances in the treatment of heart failure with a preserved ejection fraction. Current Opinion in Cardiology 23:3, 233-240
CrossRef253
Jianwen Wang, Sherif F. Nagueh. 2008. Assessment of Filling Pressure at Rest. , 53-71.
CrossRef254
Gabriel W. Yip, Cheuk-Man Yu. 2008. Assessment of Diastolic Heart Failure. , 89-101.
CrossRef255
F. Peters-Klimm, T. Müller-Tasch, D. Schellberg, A. Remppis, A. Barth, N. Holzapfel, J. Jünger, W. Herzog, J. Szecsenyi. (2008) Guideline adherence for pharmacotherapy of chronic systolic heart failure in general practice: a closer look on evidence-based therapy. Clinical Research in Cardiology 97:4, 244-252
CrossRef256
Ken McDonald. (2008) Diastolic heart failure in the elderly: Underlying mechanisms and clinical relevance. International Journal of Cardiology 125:2, 197-202
CrossRef257
K. C. R. Patel, F. Leyva, M. P. Frenneaux. (2008) Heart failure is not a diagnosis. International Journal of Clinical Practice 62:4, 526-528
CrossRef258
Yoav Michowitz, Yaron Arbel, Dov Wexler, David Sheps, Ori Rogowski, Itzhak Shapira, Shlomo Berliner, Gad Keren, Jacob George, Arie Roth. (2008) Predictive value of high sensitivity CRP in patients with diastolic heart failure. International Journal of Cardiology 125:3, 347-351
CrossRef259
Hidekatsu Fukuta, William C. Little. (2008) Observational Studies of Statins in Heart Failure with Preserved Systolic Function. Heart Failure Clinics 4:2, 209-216
CrossRef260
Anita Deswal, Lily Zhang. (2008) Treatment of heart failure with preserved systolic function in the elderly. Aging Health 4:2, 157-170
CrossRef261
Shigefumi Fukui, Yoshihiro Fukumoto, Jun Suzuki, Kenya Saji, Jun Nawata, Shunsuke Tawara, Tsuyoshi Shinozaki, Yutaka Kagaya, Hiroaki Shimokawa. (2008) Long-term Inhibition of Rho-kinase Ameliorates Diastolic Heart Failure in Hypertensive Rats. Journal of Cardiovascular Pharmacology 51:3, 317-326
CrossRef262
Robert L. McNamara, Bethany A. Austin, Yongfei Wang, Grace L. Smith, Viola Vaccarine, Harlan M. Krumholz. (2008) Systolic Function as a Predictor of Mortality and Quality of Life in Long-term Survivors with Heart Failure. Clinical Cardiology 31:3, 119-124
CrossRef263
J.A. Divisón, B. de Rivas, E. Márquez-Contreras, E. Sobreviela, M. Luque. (2008) Características clínicas y manejo de pacientes hipertensos con diagnóstico de insuficiencia cardíaca en Atención Primaria en España. Estudio HICAP. Revista Clínica Española 208:3, 124-129
CrossRef264
Christophe Tribouilloy, Dan Rusinaru, Laurent Leborgne, Marcel Peltier, Ziad Massy, Michel Slama. (2008) Prognostic Impact of Angiotensin-Converting Enzyme Inhibitor Therapy in Diastolic Heart Failure. The American Journal of Cardiology 101:5, 639-644
CrossRef265
Cecilia Linde. (2008) Future directions in cardiac resynchronization therapy. Current Heart Failure Reports 5:1, 51-55
CrossRef266
Y. O. Xu-Cai, D. J. Brotman, C. O. Phillips, F. A. Michota, W. H. W. Tang, C. M. Whinney, A. Panneerselvam, E. D. Hixson, M. Garcia, G. S. Francis, A. K. Jaffer. (2008) Outcomes of Patients With Stable Heart Failure Undergoing Elective Noncardiac Surgery. Mayo Clinic Proceedings 83:3, 280-288
CrossRef267
Akshay Desai. (2008) Current understanding of heart failure with preserved ejection fraction. Current Opinion in Internal Medicine 7:1, 1-8
CrossRef268
Dalane W. Kitzman, Jerome L. Fleg. 2008. Heart Failure. , 542-576.
CrossRef269
Steven J. Lester, A. Jamil Tajik, Rick A. Nishimura, Jae K. Oh, Bijoy K. Khandheria, James B. Seward. (2008) Unlocking the Mysteries of Diastolic Function. Journal of the American College of Cardiology 51:7, 679-689
CrossRef270
Dennis T. Ko, David A. Alter, Peter C. Austin, John J. You, Douglas S. Lee, Feng Qiu, Therese A. Stukel, Jack V. Tu. (2008) Life expectancy after an index hospitalization for patients with heart failure: A population-based study. American Heart Journal 155:2, 324-331
CrossRef271
ARUMUGAM NARAYANAN, GERARD P. AURIGEMMA. 2008. Coronary Artery Disease. , 277-286.
CrossRef272
HIDEKATSU FUKUTA, WILLIAM C. LITTLE. 2008. General Principles, Clinical Definition, and Epidemiology. , 63-72.
CrossRef273
STEVEN J. LESTER, A. JAMIL TAJIK. 2008. Echo-Based Approach to the Management of Diastolic Heart Failure. , 429-434.
CrossRef274
LIVIU KLEIN, ROBERT O. BONOW. 2008. Diabetes Mellitus. , 333-342.
CrossRef275
Lawrence Liao, Larry A Allen, David J Whellan. (2008) Economic Burden of Heart Failure in??the Elderly. PharmacoEconomics 26:6, 447-462
CrossRef276
BARRY A. BORLAUG, VOJTECH MELENOVSKY, DAVID A. KASS. 2008. Ventricular-Arterial Interaction in Patients with Heart Failure and a Preserved Ejection Fraction. , 403-412.
CrossRef277
D. DIRK BONNEMA, CATALIN F. BAICU, MICHAEL R. ZILE. 2008. Pathophysiology of Diastolic Heart Failure: Relaxation and Stiffness. , 11-25.
CrossRef278
Naomi Kawashiro, Hiroshi Kasanuki, Hiroshi Ogawa, Naoki Matsuda, Nobuhisa Hagiwara, The Heart Institute of Japan - Depa. (2008) Clinical Characteristics and Outcome of Hospitalized Patients With Congestive Heart Failure. Circulation Journal 72:12, 2015-2020
CrossRef279
Nobuyuki Shiba, Kotaro Nochioka, Haruka Kohno, Mika Matsuki, Jun Takahashi, Tomohiro Tada, Yutaka Kagaya, Hiroaki Shimokawa. (2008) Emerging Problems of Heart Failure Practice in Japanese Women. Circulation Journal 72:12, 2009-2014
CrossRef280
ANAND PRASAD, BENJAMIN D. LEVINE. 2008. Aging and Diastolic Heart Failure. , 385-401.
CrossRef281
Darcy A. Lamb, David F. Blackburn, Anne M. PausJenssen, William M. Semchuk, Patrick Robertson. (2008) Heart failure: Back to basics for pharmacists. Canadian Pharmacists Journal 141:1, 48-57
CrossRef282
Brad Stuart. (2007) The nature of heart failure as a challenge to the integration of palliative care services. Current Opinion in Supportive and Palliative Care 1:4, 249-254
CrossRef283
Masoor Kamalesh. (2007) Heart Failure in Diabetes and Related Conditions. Journal of Cardiac Failure 13:10, 861-873
CrossRef284
Jeffrey W.H. Fung, John E. Sanderson, Gabriel W.K. Yip, Qing Zhang, Cheuk M. Yu. (2007) Impact of Atrial Fibrillation in Heart Failure With Normal Ejection Fraction: A Clinical and Echocardiographic Study. Journal of Cardiac Failure 13:8, 649-655
CrossRef285
Alberto Zanchetti, Cesare Cuspidi, Lisa Comarella, Enrico Agabiti Rosei, Ettore Ambrosioni, Massimo Chiariello, Gastone Leonetti, Giuseppe Mancia, Achille C Pessina, Antonio Salvetti, Bruno Trimarco, Massimo Volpe, Nicoletta Grassivaro, Giuseppe Vargiu. (2007) Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study. Journal of Hypertension 25:10, 2158-2167
CrossRef286
Dalane W. Kitzman, Kurt R. Daniel. (2007) Diastolic Heart Failure in the Elderly. Heart Failure Clinics 3:4, 437-453
CrossRef287
Sabu Thomas, Michael W. Rich. (2007) Epidemiology, Pathophysiology, and Prognosis of Heart Failure in the Elderly. Heart Failure Clinics 3:4, 381-387
CrossRef288
Thomas C. Martin. (2007) Comparison of Afro-Caribbean Patients Presenting in Heart Failure With Normal Versus Poor Left Ventricular Systolic Function. The American Journal of Cardiology 100:8, 1271-1273
CrossRef289
Kanu Chatterjee, Barry Massie. (2007) Systolic and Diastolic Heart Failure: Differences and Similarities. Journal of Cardiac Failure 13:7, 569-576
CrossRef290
Michael Johnston, Sean P. Collins, Alan B. Storrow. (2007) The third heart sound for diagnosis of acute heart failure. Current Heart Failure Reports 4:3, 164-169
CrossRef291
Andrew C. Stone, Linda Nici. (2007) Other Systemic Manifestations of Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine 28:3, 553-557
CrossRef292
U.C. Hoppe. (2007) Leitliniengerechte Therapie der chronischen Herzinsuffizienz. Der Internist 48:9, 929-937
CrossRef293
Gregg C. Fonarow, Wendy Gattis Stough, William T. Abraham, Nancy M. Albert, Mihai Gheorghiade, Barry H. Greenberg, Christopher M. O’Connor, Jie Lena Sun, Clyde W. Yancy, James B. Young. (2007) Characteristics, Treatments, and Outcomes of Patients With Preserved Systolic Function Hospitalized for Heart Failure. Journal of the American College of Cardiology 50:8, 768-777
CrossRef294
Rebecca E. Scully, Steven E. Lipshultz. (2007) Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovascular Toxicology 7:2, 122-128
CrossRef295
Elly Barry, Jorge A Alvarez, Rebecca E Scully, Tracie L Miller, Steven E Lipshultz. (2007) Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management. Expert Opinion on Pharmacotherapy 8:8, 1039-1058
CrossRef296
C. Davidson. (2007) Heart failure: a disease for the Internist. La Revue de Médecine Interne 28, S27-S29
CrossRef297
Xiushui Ren, Bryan Ristow, Beeya Na, Sadia Ali, Nelson B. Schiller, Mary A. Whooley. (2007) Prevalence and Prognosis of Asymptomatic Left Ventricular Diastolic Dysfunction in Ambulatory Patients With Coronary Heart Disease. The American Journal of Cardiology 99:12, 1643-1647
CrossRef298
Taiyeb M. Khumri, Madhuri Idupulapati, Valerie J. Rader, Sunil Nayyar, Casey N. Stoner, Michael L. Main. (2007) Clinical and Echocardiographic Markers of Mortality Risk in Patients With Atrial Fibrillation. The American Journal of Cardiology 99:12, 1733-1736
CrossRef299
Hidekatsu Fukuta, William C. Little. (2007) Diagnosis of diastolic heart failure. Current Cardiology Reports 9:3, 224-228
CrossRef300
Brian Moore, Peter H. Brubaker, Kathryn P. Stewart, Dalane W. Kitzman. (2007) VE/VCO2 Slope in Older Heart Failure Patients With Normal Versus Reduced Ejection Fraction Compared With Age-Matched Healthy Controls. Journal of Cardiac Failure 13:4, 259-262
CrossRef301
Luigi Tavazzi. (2007) Nebivolol for heart failure in the elderly. Expert Review of Cardiovascular Therapy 5:3, 423-433
CrossRef302
Koracevic Goran. (2007) Diastolic, But Not Systolic Blood Pressure at Admission Predicted Long-term Mortality in Acute Cardiogenic Pulmonary Edema. The Journal of Heart and Lung Transplantation 26:5, 556
CrossRef303
Viorel G. Florea, Inder S. Anand. (2007) Predicting survival in heart failure. Current Cardiology Reports 9:3, 209-217
CrossRef304
Stephen Westaby. (2007) Surgery for Heart Failure: Now Something for Everyone?. Heart Failure Clinics 3:2, 139-157
CrossRef305
C. Verny. (2007) Congestive heart failure in the elderly diabetic. Diabetes & Metabolism 33, S32-S39
CrossRef306
Jesper Kjaergaard, Dilek Akkan, Kasper Karmark Iversen, Erik Kjoller, Lars Køber, Christian Torp-Pedersen, Christian Hassager. (2007) Prognostic Importance of Pulmonary Hypertension in Patients With Heart Failure. The American Journal of Cardiology 99:8, 1146-1150
CrossRef307
Fernando Otero-Raviña, Lilian Grigorian-Shamagian, Luis Fransi-Galiana, Carlos Názara-Otero, José M. Fernández-Villaverde, Alberto del Álamo-Alonso, Enrique Nieto-Pol, Miguel de Santiago-Boullón, Isidro López-Rodríguez, José M. Cardona-Vidal, Alfonso Varela-Román, José R. González-Juanatey. (2007) Estudio gallego de insuficiencia cardiaca en atención primaria (estudio GALICAP). Revista Española de Cardiología 60:4, 373-383
CrossRef308
William G. Stevenson, Usha Tedrow. (2007) Management of atrial fibrillation in patients with heart failure. Heart Rhythm 4:3, S28-S30
CrossRef309
Sabu Thomas, Michael W. Rich. (2007) Epidemiology, Pathophysiology, and Prognosis of Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 1-10
CrossRef310
Dalane W. Kitzman, Kurt R. Daniel. (2007) Diastolic Heart Failure in the Elderly. Clinics in Geriatric Medicine 23:1, 83-106
CrossRef311
W.H. Frishman. (2007) Systolic and Diastolic Heart Failure in the Community. Yearbook of Medicine 2007, 360-362
CrossRef312
Akira Esumi, Shinji Nakao, Akiko Goda, Misato Otsuka, Mika Matsumoto, Chikako Yoshida, Akiyo Eguchi, Miho Shimoshikiryo, Yoshiro Naito, Masaaki Lee, Takeshi Tsujino, Tohru Masuyama. (2007) Left Ventricular Geometrical Characterization in Patients With Diastolic Heart Failure. Journal of Echocardiography 5:1, 28-31
CrossRef313
Jaekyu Shin, Maximilian T. Lobmeyer, Yan Gong, Issam Zineh, Taimour Y. Langaee, Hossein Yarandi, Richard S. Schofield, Juan M. Aranda, James A. Hill, Daniel F. Pauly, Julie A. Johnson. (2007) Relation of β2-Adrenoceptor Haplotype to Risk of Death and Heart Transplantation in Patients With Heart Failure. The American Journal of Cardiology 99:2, 250-255
CrossRef314
Muneyoshi Ogawa, Fumitaka Tanaka, Toshiyuki Onoda, Masaki Ohsawa, Kazuyoshi Itai, Toshiaki Sakai, Akira Okayama, Motoyuki Nakamura, The Northern Iwate Heart Disease Re. (2007) A Community Based Epidemiological and Clinical Study of Hospitalization of Patients With Congestive Heart Failure in Northern Iwate, Japan. Circulation Journal 71:4, 455-459
CrossRef315
María G. Crespo Leiro, Manuel Jiménez-Navarro, Fernando Cabrera Bueno, Pedro L. Sánchez. (2007) Insuficiencia cardiaca en el año 2006. Revista Española de Cardiología 60, 58-67
CrossRef316
G.P. Gravlee. (2007) Outcome of Heart Failure with Preserved Ejection Fraction in a Population-Based Study. Yearbook of Anesthesiology and Pain Management 2007, 72-73
CrossRef317
J. Malcolm O. Arnold, Jonathan G. Howlett, Paul Dorian, Anique Ducharme, Nadia Giannetti, Haissam Haddad, George A. Heckman, Andrew Ignaszewski, Debra Isaac, Philip Jong, Peter Liu, Elizabeth Mann, Robert S. McKelvie, Gordon W. Moe, John D. Parker, Anna M. Svendsen, Ross T. Tsuyuki, Kelly O’Halloran, Heather J. Ross, Vivek Rao, Errol J. Sequeira, Michel White. (2007) Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers. Canadian Journal of Cardiology 23:1, 21-45
CrossRef318
W.H. Wilson Tang, Gary S. Francis. (2006) The Year in Heart Failure. Journal of the American College of Cardiology 48:12, 2575-2583
CrossRef319
O. M. P. Jolobe. (2006) Usefulness of Left Ventricular Ejection Fraction in Patients With Overt Heart Failure. Mayo Clinic Proceedings 81:12, 1638-1639
CrossRef320
(2006) Heart Failure with Preserved Ejection Fraction. New England Journal of Medicine 355:17, 1828-1831
Full Text321
Aurigemma, Gerard P., . (2006) Diastolic Heart Failure — A Common and Lethal Condition by Any Name. New England Journal of Medicine 355:3, 308-310
Full Text
- Letters
